### Comprehensive Report on Global Medication Shortages (2021–2024)

#### Introduction
Medication shortages have become a growing global concern, affecting both developing and developed countries.

These shortages stem from various causes, including supply chain disruptions, demand spikes, and manufacturing delays.

This report highlights real-world examples of how these shortages have impacted ordinary patients and how authorities responded.

---

### Case 1: Lebanon – Drug Shortages Amid Economic Crisis (2022)

#### Affected Medications
- Medications for chronic diseases such as **diabetes**, **heart disease**, **epilepsy**, and **cancer**.

- Essential drugs used in **intensive care units** (ICUs) in hospitals.

#### Reasons Behind the Shortages
1.

**Economic Collapse**: Lebanon's severe economic crisis led to a devalued currency, making it difficult to import medications priced in U.

S.

dollars.

**Drug Smuggling**: A significant portion of

### Comprehensive Report on Global Medication Shortages (2021–2024)

#### Introduction
Medication shortages have become a growing global concern, affecting both developing and developed countries.

Title:

Content: There is not enough medicine in the EU
19 January 2023, 05: 20
ASTANA.
KAZINFORM - The European Union is suffering from a shortage of medicines.
Deficiency of antibiotics, such as amoxicillin, drugs against colds, flu and other respiratory infections, as well as some drugs for children, reports MIA "Kazinform" with reference to euronews.com.
In most countries, the situation is considered critical, but since such goods from pharmacies do not disappear at all, citizens are not advised to make stocks.
Doctors note a weakening in the population of natural immunity due to protection against coronavirus such as social distancing.
The main reasons for the sharp increase in demand, which have been identified, is the high prevalence of respiratory diseases with a lack of production capacity.
As pharmaceutical issues are being addressed at the national level, Governments are already taking steps to overcome the shortage
These measures include the sale of generics and the replacement of requested medicines with similar ones.
In some countries, some formulations have been changed, for example, drugs are offered in the form of syrups instead of tablets, so that children are more willing to take them.
"Pediatric drugs are generally now less available in the form of conventional tablets," said Steffen Tierstrup, chief medical officer of the European Medicines Agency. "Therefore, where children are more ill, the need for pediatric drugs is higher than for adult drugs."
A recent study showed that the shortage of drugs in Spain increased by 38% over the year.
The decline in their production was affected by inflation, high energy prices, shortages of raw materials and the effects of the pandemic.
“We need diversification, ” said Ilaria Passarani, head of the EU Pharmaceutical Group.“ Of course, it would be useful to return to Europe the production of some critical materials, such as active ingredients.
But we can't return all the production of all the materials we use for drugs.
This entails problems such as the increase in pharmacy prices associated with the implementation of environmental laws, labor laws, which are not necessarily enforced in other regions. ”
In March, the European Commission will present a revised version of the EU pharmaceutical legislation, which will include stricter supply obligations, earlier notification of shortages and seizures of medicines, and better informing the public about available stocks.
News on the topic
Partners news
News feed

Title:

Content: Thursday, 14 Jumada I 1444 Hijri, corresponding to 08 December 2022 AD
A medical crisis in Kuwait.
Urgent parliamentary action
Contact – Editorial Team:
Two deputies in the Kuwaiti National Assembly submitted two requests to the Parliamentary Health Affairs Committee to study the causes of the shortage of medicines, which has become a crisis threatening the health of Kuwaitis, according to media reports.
Medications are not available for dispensing
MP Dr. Jenan Bushehri sent a letter to the National Assembly, in which she confirmed that “despite the assurances of officials in the Ministry of Health of sufficient pharmaceutical stock for the community, many medicines are not available for disposal, which makes the general health situation on the verge of collapse, ” according to“ Al-Qabas ”.
Boushehri asked the Health Affairs Committee to study the causes of the shortage of medicines in private and private health institutions and centers, and to submit its report in the next session, including the causes, results, recommendations and those responsible for the crisis.
The MP stressed that all constitutional options are available in the event of any complacency or inaction in the development of permanent solutions that preserve the health of the population of the State of Kuwait.
Also read:
18 "homosexuals" arrested in a massage and massage center in Kuwait..
They committed adultery and lured teenagers.
200 drugs not available
MP Faisal al-Kandari asked Prime Minister Sheikh Ahmed Nawaf al-Ahmad al-Sabah to form an investigation committee on the lack of medicines and irregularities in the Ministry of Health, and said: "We will wait for the results before using constitutional tools."
Al-Kandari added: “I continue to extend a helping hand to the government for the benefit of Kuwait and its people, and I have gradually used constitutional tools, waiting for the procedures to address the issue of the unavailability of more than 200 types of medicines. ”

Title:

Content: ROSBALT
640 followers
WHO: The world faces a shortage of syringes due to vaccination against coronavirus
The World Health Organization (WHO) predicted next year a shortage of medical syringes, which will be observed worldwide due to the need to continue vaccination against COVID-19.
Back to article
Picture of the day
top

Title:

Content: Nationwide Adderall shortage impacting area pharmacies in the Panhandle

Published: Oct. 19, 2022 at 5:07 PM CDT|Updated: 19 minutes ago

AMARILLO, Texas (KFDA) - The Food and Drug Administration has declared a nationwide Adderall shortage and the Panhandle is feeling the affects.

The FDA blames the shortage on manufacturing delays.

Health experts say a shortage in stimulant medications is actually not a rare occurrence.

“The amount of medication that is produced is limited and regulated by the government, so there have been other years where towards the end of the year in particular, we start to struggle with supply issues. In this case, however, while that does seem to be probably one of the contributing factors, the other issue we’re facing, at least what we’re hearing about it right now, is that the manufacturing delays have been an issue and some of that has been secondary to the labor shortages,” said Dr. Carolyn Lentsch-Parcells, pediatrician and assistant professor at Burnett School of Medicine at TCU.

Martin Tipton Pharmacy is being impacted by this shortage.

“We’re having to order from various manufacturers right now, not our normal manufactures just because we cannot get them from our normal ones,” said Mark Vogler, Martin Tipton Pharmacy.

Fortunately its patients have been able to get their needed medication, just a different brand.

Amarillo Pharmacy is also being impacted, saying the drug has been back ordered for the past two months.

The Amarillo Pharmaceutical Care Center at Texas Tech Physicians is also seeing a back order on one of the strengths of the drug.

“The drug company manufacturers short-acting and extended-release, for example. So, a pharmacist, in this situation, will work collaboratively with the patient’s provider to find an available strength and dosage to meet the patient’s needs until the original strength becomes available again,” said Amarillo Pharmaceutical Care Center at Texas Tech Physicians.

Dr. Lentsch-Parcells acknowledged this may be an uneasy time for those depending on Adderall, especially with the end of the semester and holidays approaching. She encourages you to reach out to your providers.

“There are various strategies that we will sometimes use to help our patients get the best care possible, while we are trying to ride out the shortage, so that might be changing dosage or using dosage forms that are available to replace their typical medication,” said Dr. Lentsch-Parcells

She emphasizes not to make any changes to your medications without speaking to your providers first.

Pharmacy chains, like CVS and Walgreens, both confirm they are seeing intermittent supply issues with the generic form of the drug.

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
Haaretz: West Bank and Gaza face severe and serious shortage of medicines for patients
The Hebrew newspaper Haaretz, on Thursday, June 8, 2023, revealed a severe shortage suffered by the Palestinian Ministry of Health, due to the financial crisis of the Authority.
The West Bank and Gaza Strip are facing a severe and serious shortage of medicines for Palestinian patients, especially patients with chronic and serious diseases, who are difficult to obtain their medicines.
One of the doctors working in the dialysis center at the government hospital in the northern West Bank city of Tubas said that this crisis has been clearly felt for several weeks, and patients come from several areas to get medicines for dialysis patients and we have no way to help them, pointing out that there are those who have the ability to buy these medicines, but the vast majority of the population does not have this ability.
A senior PA official told the Hebrew daily that the shortage of medicines in the West Bank stems from three main reasons: the inability of the PA and the Ministry of Health to pay regularly to suppliers, as well as the strike of pharmacists in medical centers and hospitals for not receiving full salaries, in addition to the closure by UNRWA in recent months of medical centers run in refugee camps due to budget shortages.
This is in addition to the fact that the PA ’ s entire budget is based on tax money collected by Israel, which barely covers payroll expenses, including in the Ministry of Health, and since Israel deducts hundreds of millions of tax funds, the PA does not have the capacity to fund the PA ’ s ministry budget, the official said.
According to Physicians for Human Rights (PHR), there has been a dozens of percent jump in the number of Palestinian patients who have arrived in recent weeks at the mobile clinic that runs PHR in the West Bank, and a sharp increase in demand for medicines.
The data indicates that on Saturday, 251 Palestinians out of 2,500 living in the village of Madma in Nablus arrived at the mobile clinic to obtain medicines and receive treatment, and during a medical day held in Beta in Nablus last month, 405 patients came to the clinic, double the number of patients who used to come from that area in previous periods.
The association pointed out that due to the severe shortage of medicines, recent weeks have seen an increase in requests received from Palestinian medical teams and mayors of cities and villages in the West Bank to distribute medicines and medical equipment, including medicines for patients with dialysis, diabetes, blood pressure and others.
In the Gaza Strip, the Ministry of Health issued warnings about the consequences of the shortage of medicines for kidney patients, noting that 1,200 patients are at risk of stopping their treatment due to severe shortages of essential medicines and medical equipment.

Title:

Content: Pharmaceuticals Division: Saudi Arabia and the Gulf States have shortcomings like theirs..
A complete breakthrough in 3 months - Sunrise Gate
Friday 26 July 2024 1: 46 AM Cairo Cairo 24 °
Most Read
You might like it, too.
Share your opinion
Do you support calls to boycott some restaurants that have been proven to support the occupation soldiers?
Pharmaceuticals Division: Saudi Arabia and the Gulf States have shortcomings like theirs..
Full release in 3 months.
Mohamad Shaaban
Published on: Friday 26 July 2024 - 1: 04 AM | Last updated on Friday 26 July 2024 - 1: 04 AM
Dr. Alaa Auf, head of the pharmaceutical division of the Federation of Chambers of Commerce, said that the market is witnessing daily pumping of regular production from factories, adding: « The availability of medicines began to be very tangible this week, and important shortcomings began to appear in the market and are available, and patients began to organize on their usual medicines ».
He added during statements to the program « Thursday Dialogue » broadcast on the screen « Event Today », that the end of the crisis is expected in two or three months, stressing that the solution to the shortage of drugs lies in writing the scientific name of the drug instead of the trade name.
He expressed his dissatisfaction with the current situation, explaining that the image of Egypt abroad shows it as if it is without medicines, while the reality is its availability, but the problem lies in the culture of the patient and doctors who rely on the brand names of medicines.
He stressed that each medicine has 20 to 30 alternatives, adding: "I am not satisfied with the current situation, because the image of Egypt abroad shows that it does not have medicine, while we have medicine, but the problem is in the culture of the patient and the habits of doctors are the basis of the problem.
Saudi Arabia and the Gulf states have shortcomings like their own, but they deal with the scientific name, so no one hears about a drug crisis in these countries. ”
Dr. Khaled Abdel Ghaffar called on the Minister of Health to issue instructions obliging doctors to write the drug in the prescription under the scientific name, stressing that if applied, Egypt will not suffer from a drug crisis.
He pointed out that the Drug Authority has set controls focused on the provision of medicines in areas suffering from shortage, while areas suffering from less shortage will receive medicines later, expecting that citizens will feel better within a week or ten days.
You might like it, too.
Share your comment

Title:

Content: Chairman of the Board of Directors and Editors
Mohamad Elbaz
Chairman of the Board of Directors and Editors
Mohamad Elbaz
The Minister of Health has promised to solve the problem of lack of medicine.
He added that the private sector will be involved in the management of hospitals.
In response to a question from MP Mustafa Salem, Undersecretary of the Planning and Budget Committee, in the meetings of the Committee today to discuss the budget of the Ministry of Health and its affiliates, Minister of Health, Dr. Khalid Abdul Ghaffar, stressed that the resources available to the Ministry of Health are insufficient to provide appropriate services according to the standards set.
He added that the private sector will be involved in the management and operation of some hospitals from the beginning, or existing hospitals, which have problems and mismanagement.
He explained that the prices will not increase at all, and the citizen will not be harmed because he will receive the best service at the same prices without any increase, pointing out that the patient instead of going to the hospital and does not find the appropriate service or does not find the required doctor will go to hospitals at any time and find the appropriate medical service night and day.
Lack of medication
Regarding the shortage of medicine, Abdel Ghaffar stressed that the previous period was a problem due to the dollar crisis, which is almost non-existent now, but the production lines in the factories are still not ready to work with the same efficiency and sufficient production capacity required.
He pointed out that most drugs away from oncology drugs and some other diseases are produced 95% of them locally.
He added that the cost of producing the treatment has increased significantly, and the producers are exposed to large losses, and a meeting has been held between the ministry and the competent chambers, the Unified Procurement Authority, the Drug Authority and all concerned parties to develop appropriate solutions to this problem and maintain the pharmaceutical industry.
On the position of the hospitals being implemented, especially in Sohag, Dr. Anwar Ismail, Assistant Minister, said that 20 hospitals will be handed over and operated this year in the Republic, including in the governorate of Sohag, Sagalta General Hospital and Gerga General Hospital. He added that 10 new hospitals will be established this year, including one in Sohag.

Title:

Content: Drug supply problems have worsened in Estonia
This year, pharmacies in Estonia faced a much larger shortage of drugs than a year earlier.
Problems with supplies are caused by both increased demand and shortage of raw materials, reports rus.err with reference to "Actual chamber".
This spring, parents faced a shortage of antibiotics and antipyretic drugs suitable for children, and in the fall, the Sorbister drug for renal patients had to be issued from the state reserve stock, since it was not enough due to supply problems in pharmacies.
Hospitals are also facing a severe shortage of medicines this year.
“For example, hospitals use very important drugs to treat the consequences of heart attacks and strokes, the supply problems of which have been observed for a year, but thanks to good cooperation, we were able to ensure that no one was left without treatment, ” said Marco Tiisler, head of the Import and Export Supervision Department of the Drug Department.
In 2021, there was a shortage of 183 drugs in pharmacies, last year - 359, as of the end of this year - 450 drugs, and in the case of 130 drugs, the cause of the deficiency is unknown.
The second significant reason was a sudden surge in demand, for example, for the drug Ozempic, which is popular among those who lose weight, but drugs can be in short supply due to problems with production.
- Producers lack the active ingredient.
The active substances come from third countries, they are not always available, this was stated by one of the largest European manufacturers of antibiotics, - said Tiisler.
Drug supply problems put not only patients in a difficult position, but also doctors who have to quickly find replacements, sometimes in conditions of scarce information about alternatives.
If earlier, in the case of a shortage of drugs, the patient had to pay the full cost of the drug prescribed as a substitute, recently the Health Insurance Fund, as an exception, decided to extend the discount to some alternatives.
According to Lee Rootslane, head of the Union of Pharmacies, problems with the supply of medicines are a growing problem throughout Europe.
- This year, in cooperation with the Drug Department and family doctors, we made recommendations so that if a problem arises, we do not solve it after the fact, but try to provide some solutions and avoid panic.
In the case of children ’ s syrups, people read about the shortage of syrup, went to the pharmacy and took two syrups instead of the usual one, ” Rootslane said.
The drug department recommends having a weekly supply of non-prescription drugs and a monthly supply of prescription drugs at home.
Comments
Back to top

Title:

Content: Lebanon..
Medication crisis is the talk of communication platforms and the army documents warehouse raids (Video)
With the continuation of the Lebanese crisis, the search for medicines has become a daily habit for thousands of Lebanese citizens, especially with the scarcity of a number of them, especially medicines for chronic diseases, and the scarcity of foreign exchange required to import these important treatments has complicated matters.
The pioneers of social media platforms in Lebanon expressed their anger and resentment at the poor conditions reached by the medical sector, in light of the stockpiling of medicines by some monopolists for the purpose of selling them at high prices without taking into account the health conditions of patients.
One of the activists tweeted: “Every pharmacist is motivated by the owners of drug cartels monopolized by being afraid of his interests and participating with them or benefiting from them and afraid to play the role. ”
Another asked, “Why are you silent, people of Lebanon, and what are you silent about your state of suffering while your leaders have medicine, food, fuel, electricity and they have worked as slaves. ”
The head of the parliamentary health committee Issam Araji tweeted, “The apparent process of forming the government Talaat Tabkha Bahs, your place is Roh.
A major interruption in medicines and medical supplies and on the market dollar price, and patients are unable to pay the imaginary costs of hospitalization and the war of stations and bread.
Immigrants at the airport.
And outrageous prices.
“A described lack of responsibility aimed at destroying the country and its regime. ”
Since 2020, the features of a shortage of medicines in the local market began due to the lack of the dollar necessary for imports, as was the case with wheat and fuel of all kinds.
Recently, the Lebanese Armed Forces raided warehouses where large quantities of medicines were stored for sale at the black market price.
The Lebanese army posted videos on Twitter documenting its raid.
Last month, Lebanese Health Minister Hamad Hassan announced the seizure of tons of medicines hidden in warehouses in the center and south of the country, at a time when Beirut is suffering from a severe shortage of medicines.
Hassan ordered the sale of existing medicines to citizens and pharmacies, especially infant formula and necessary medicines, in the presence of the pharmaceutical inspection body of the Ministry of Public Health.
In the context, a UN official, on Saturday, expressed surprise at the “indifference ” of Lebanese officials to the situation of the people in the country, who are suffering from difficult living conditions.
This came according to the Special Representative of the Secretary-General of the United Nations in Lebanon, Joanna Frontska, during her meeting with Maronite Patriarch Mar Bishara Boutros Al-Rai in the summer patriarchal edifice in the town of Diman (North), according to the official Lebanese News Agency.
Frontska said she was "surprised by the indifference of officials to the situation of the people who are suffering due to the difficult living situation."
The agency quoted the sponsor as praising "the initiatives undertaken by the United Nations towards Lebanon," expressing hope "for more support so that the Lebanese citizen can withstand the crises he is experiencing."
After the meeting, Frontska said in a statement to reporters that "Lebanon needs urgent solutions, especially the formation of a government," stressing that the United Nations "will continue to support Lebanon," according to the same source.
Due to political differences, Lebanese officials have been unable to form a new government for more than a year to end the economic collapse and succeed the current caretaker government, which resigned six days after a catastrophic explosion at the Beirut port on August 4, 2020.
Since late 2019, Lebanon has been suffering a severe economic crisis that has led to a financial collapse, the loss of fuel, medicines and other basic goods, as well as a record rise in poverty and unemployment.
Source: Al Jazeera Mubasher + Social Media + Agencies
About this story
More News
Most Read

Title:

Content: Israel faced an acute shortage of various drugs: the Association of pharmacists announced the details
Pharmacists said that the problem is not properly solved by state bodies, in particular the Ministry of Health.
The Association of Pharmacists has warned of an acute shortage of drugs, including Ritalin, drugs used to treat heart and blood vessel problems, and drugs to treat skin diseases.
Pharmacists wrote about it in a letter sent to Health Minister Nietzan Horowitz and his office ’ s CEO, Nachman Ashe, on Monday.
There is a shortage of medicines in Israel.
In the past two years, and in particular in the last few months, the phenomenon of shortages has intensified, ” said David Pepo, chairman of the Association of Pharmacists.
“The shortage is understandable for a number of reasons: COVID-19, the war in Ukraine, the global employment crisis and the economic crisis, ” Pepo explained.
“To this should be added the serious disruptions taking place in the distribution systems of medicines in Israel, which are due to staff shortages, malfunctions, high distribution costs and many other explanations of all sorts, ” Pepo said.
Earlier, Cursor wrote that in supermarkets in the coming days, a shortage of chicken and turkey is expected.
Recall that scientists have named a substance that reduces the risk of suicide.
In addition, the Minister of culture Healy Tropper said whether to cooperate with Netanyahu.
Read the latest news from Israel and the world on the Kursor channel in Telegram.
Author of the material:
TAGS:

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: NEWS
NEWS
Roszdravnadzor warned about temporary delays in the supply of medicines to pharmacies
Roszdravnadzor informed about the high probability of temporary delays in the supply of medicines to Russian pharmacies.
According to the ministry, this is due to high demand among buyers and logistical difficulties from both suppliers and manufacturers.
However, the situation began to use fraudsters.
They began to offer to buy drugs with home delivery, making an advance payment in advance.
Experts have warned that such drugs may be fake.
Details – on the air of the TV channel Moscow 24.
close
Contact Us
Feedback form
Attach file
Send
close

Title:

Content: In Israeli pharmacies shortage of drugs: details
The shortage is due to logistics problems and increased demand.
In health insurance funds and private pharmacies, there is an acute shortage of cold medicines, the demand for which is growing in the winter.
This is reported by Mako.
In many pharmacies, it is impossible to find individual types of "Akamol" (paracetamol).
There was a shortage of medicines for colds, coughs, sore throats.
The shortage is due, among other things, to logistics problems and increased demand.
Pharmacists Association Chairman David Pepo spoke to the deputy director of the Department of Pharmacy at the Ministry of Health last week, and nothing has been done since, he said.
Earlier we told that soon in Israel will launch a pilot project on the operation of autonomous buses, which will result in the country will appear commercial bus routes with cars without drivers.
Now announced four groups of companies that have won the competition of the Ministry of Transport for the implementation of the pilot project.
The cost of the pilot project is 61 million shekels, half of which is provided by the state.
It was organized jointly by the Ministry of Transport, the Public Transport Authority, the Innovation Authority and Netivei Ayalon.
Find out more here.
Cursor also reported that the number of tourists in Israel has been growing since the beginning of the year.
So, since January 2022, 2.2 million tourists have visited the country.
There was also an increase in the number of Israelis who left the country as tourists.
In addition, the Ministry of Health took measures in connection with concerns about the shortage of epidural anesthesia kits.
Read the latest news from Israel and the world on the Kursor channel in Telegram.
Author of the material:
TAGS:

Title:

Content: Balambri: Insulin contraceptives and eye drops...
Few Medicines in Algeria
The President of the National Union of Private Pharmacists, Massoud Belambri, confirmed the scarcity of many medicines in Algeria.
Similar to eye drops, insulin, birth control pills, some types of anti-inflammatory drugs, and hormones.
Massoud Belambri said in an interview with the national radio Setif that the concern in scarcity is related to imported medicines, because it takes time to re-provide them.
The same spokesman stressed that there is a fluctuation in the availability of insulin despite the import of quantities of it, but the suffering has been continuous for more than a year, pointing out that a laboratory dominates the global and local market by 80%, at least three laboratories supply Algeria with insulin.
The head of the National Syndicate added: “According to the information available to us, the start of production of insulin locally will be in the first half of the year 2023. ”
“In the first phase, 50 percent of the national needs will be covered with the entry into service of the three insulin production projects in Algeria (Constantine, Boufarik and Oued Samar). ”
In a different context, Belambri said: “Conditional sale of medicines has decreased compared to previous years thanks to the interaction of pharmacists.
“Reporting via the digital platform of the Ministry of Pharmaceutical Industry, and we regret that the distributors did not denounce the practices of laboratories. ”
He continued the same spokesman by saying: "The conditional sale is caused by scarcity if drugs are available in the necessary quantities when resorted to any party to the conditional sale neither the informant nor the producer nor the importer nor the distributor," stressing that the elimination of conditional sale is the provision of medicines, tightening control, and recourse to professional ethics and responsibility.
Ramzi Ahmed Tomiat
Related Articles
Go to the top button
% d bloggers like this:

Title:

Content: svoyblog
4 followers
The Ministry of Industry and Trade announced the risk of a shortage of vital drugs
The Ministry of Industry and Trade of Russia receives information from the regions about the lack of immunoglobulin preparation.
This was told in the department.
Back to article
Picture of the day
top

Title:

Content: Locally
2022-08-02 04: 30: 55
Daily News
The shortage of commonly used pharmaceutical factories has led to the unusual practice of the Mainland and Western Medicine Hospital Authority
Share:
Hospital Authority Director of Cluster Services, Mr Tang Yiu-keng (pictured), pointed out that because of the shortage of paracetamol, the Hospital Authority purchased paracetamol tablets from the Mainland. He pointed out that when the situation is urgent, it is very unusual to use the designated patient drug use plan to introduce drugs. Production to avoid common drug shortages.
As for the earlier switch to the mainland antibiotic "cefoxidine for injection", which was also supplied by the original drug manufacturers, the mainland version was imported to cope with the sudden surge in demand.
The supply situation is stable and the use of the same antibiotics as the original contract has been restored.
Chief Pharmacist of HA, Mr Lee Shing-cheung (first from left), said that the percentage of pharmaceutical products purchased by HA in China remained stable at about 3%, with no significant increase.
Mr Tang reiterated that the Bureau will adhere to four major principles when purchasing drugs, including whether the drugs are registered and GMP regulated by the Department of Health; ensure product specifications by means of medicines; pass non-proprietary drug interchangeability tests and demonstrate bioequivalence to the World Health Organization (WHO) requirements; and give priority to the use of drugs with English drug names on the label.
Privacy Protection Policy
Please read and accept the following privacy policy and disclaimer carefully. By clicking "Accept", you agree to and agree to the privacy policy and disclaimer contained in the am730 website.
LEARN MORE
Acceptance

Title:

Content: Advertisement

London man without medication after Shoppers Drug Mart systems issue

A technical issue for Shoppers Drug Mart has left one London man without medication for days.

Roy Steinbach says he went into his local Shoppers last Saturday to get his various prescriptions filled. He says he was turned away due to a systems issue.

Loblaws, the parent company of Shoppers Drug Mart, confirmed Thursday that the pharmacy has been experiencing issues with drug prescriptions for several days.

A spokesperson for Loblaws says intermitted issues have impacted some locations’ ability to fulfill prescriptions.

The company says most stores are back online and working through the resulting backlog. It added there was no systems or data breach.

Read more: Food inflation — Shoppers turn to saving hacks long used by older Canadians

Read next: Ford government to allow out-of-province nurses to start work immediately in Ontario

Story continues below advertisement

While Loblaws says the issue has been mostly resolved, Steinbach’s problems have only continued.

Steinbach says after not being able to fill his prescription over the weekend, Shoppers Drug Mart is now trying to charge him hundreds of dollars even though his medication is covered through the Ontario Disability Support Program.

Steinbach says after attempting to fill his multiple prescriptions last Saturday, he received a call earlier this week saying they were ready.

However, he was told on the phone he would be billed for some of the medicine.

After first paying and receiving an immediate refund, Steinbach says Shoppers called him Thursday requesting an up-front payment totalling $280 for some of the medication.

Read more: ‘Nothing is available’ — Pharmacies experiencing shortage of adult cold and flu medication

Read next: Halifax doctors worry announced ER improvements won’t work due to lack of beds

As a pensioner on the ODSP, Steinbach says he cannot afford the prescriptions.

“I have medications that I absolutely need daily and so I’ve been out for a few days and I’m afraid of getting sick,” Steinbach said.

Steinbach says in his most recent communication with the pharmacy Thursday, Shoppers told him it now had no record of him being on ODSP or being charged and then refunded just days ago.

Story continues below advertisement

“I don’t understand with such a large company why they haven’t fixed it yet,” said Steinbach, who added he has not received any estimate of when his issue could be resolved.

No alternatives were proposed to Steinbach by the pharmacy in how to remedy the situation, he says.

Shoppers did not provide an answer on when all issues can expect to be resolved.

Sponsored content

Title:

Content: 2 major drugs are in short supply, FDA says. Both are widely prescribed to children.

NEW!

Drug shortages continue in the U.S., even as the COVID-19 pandemic nears the end of its third year.

Two drugs commonly prescribed to children — Adderall and liquid amoxicillin — recently joined the list, the Food and Drug Administration says.

The FDA announced last month that it was talking to manufacturers about a shortage of Adderall, the combination drug of amphetamine mixed salts used to treat attention deficit hyperactivity disorder.

Parents are also discovering liquid amoxicillin — an important antibiotic used to treat bacterial infections — is in short supply, according to the FDA. It added the oral solution of the antibiotic to its list of drug shortages on Oct. 28.

Both drugs are widely used by children as well as adults. The amoxicillin shortage comes at a vulnerable time, as we enter cold and flu season and U.S. hospitals continue to fill with respiratory infections. Amoxicillin is often used to treat ear infections and bronchitis.

The reason for the shortages? The FDA didn’t immediately respond to a request for comment Thursday. However, the agency cited a few factors on its website, including quality and manufacturing issues.

“There have been other reasons such as production delays at the manufacturer and delays companies have experienced receiving raw materials and components from suppliers,” the agency says. “Discontinuations are another factor contributing to shortages.

“FDA can’t require a firm to keep making a drug it wants to discontinue. Sometimes these older drugs are discontinued by companies in favor of newer, more profitable drugs.”

For a list of all drugs currently in short supply, visit FDA.gov.

Our journalism needs your support. Please subscribe today to NJ.com.

Spencer Kent may be reached at skent@njadvancemedia.com.

If you purchase a product or register for an account through one of the links on our site, we may receive compensation.

Title:

Content: The Most Fashionable
243 followers
Missing from pharmacies vital medicine will arrive the next day
The Minister of Health of Karelia announced when and where it will be possible to buy Eutirox The head of the Ministry of Health of Karelia publicly responded to appeals about the shortage of the vital drug Eutirox.
Back to article
Picture of the day
top

Title:

Content: Right now
-1 ˚ C
Now in St. Petersburg
-1 ˚ C
Cloudy, little snow
It feels like -3.
1 m / s, south
758mm
88%
Read more
Traffic jams
3 / 10
December 20 - round table "Leaders on the main thing: what happened in medicine in 2022"
1386
Not yet having time to go from the coronavirus, the medical industry has faced the consequences of sanctions.
Despite the fact that most companies promised not to affect medicine, logistics became more complicated, prices for drugs and equipment) grew along with the exchange rate of foreign currencies (and then did not fall back so quickly).
What was the year 2022 for medicine in general and for individual clinics — in particular, we will discuss at a round table.
Questions for discussion:
- What influenced the medical industry in 2022: covid, sanctions, other factors?
- What challenges did medicine face and how did it address them?
- Demand for private medicine in 2022: what influenced it?
In which segments was the growth?
- The main achievements of medical companies in 2022 - what contributed to the success?
Did medical services go up in 2022?
Where is the growth stronger?
- Has the medical sector received any support from the state?
Is it needed and in what form?
- New and old players - how will the market of medical services develop?
Heads and doctors of medical institutions are invited to participate
According to the results of the round table, a publication is planned on the Doctor Peter website with an announcement on Fontanke.ru.
For participation, please contact:
Irina Egorova, tel.
8 – 951 – 640 – 88 – 72, egorova @ fontanka.ru
Plan of activities
LIKE0
LAUGHT0
SURPRISION0
RAGE0
FURNITURE0
JOIN NOW
The brightest photos and videos of the day - in our groups in social networks
Did you see the typo?
Select a fragment and press Ctrl + Enter
report news
Send your news to the editor, tell about the problem or throw a topic for publication.
Upload your video and photo here.

Title:

Content: Global Smart Medical Devices Market to Reach $60.1 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Smart Medical Devices Industry" - https://www.reportlinker.com/p06032911/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Smart Medical Devices Market to Reach $60.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Smart Medical Devices estimated at US$24.7 Billion in the year 2022, is projected to reach a revised size of US$60.1 Billion by 2030, growing at aCAGR of 11.8% over the period 2022-2030. Diagnostics & Monitoring Devices, one of the segments analyzed in the report, is projected to record 11.4% CAGR and reach US$40 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Therapeutic Devices segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.4 Billion, While China is Forecast to Grow at 11% CAGR

The Smart Medical Devices market in the U.S. is estimated at US$7.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.2 Billion by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 9.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Select Competitors (Total 33 Featured)
- Abbott Laboratories
- Apple Inc.
- Dexcom, Inc.
- Everist Genomics
- F.Hoffmann-La Roche Ltd.
- Fitbit, Inc.
- Johnson & Johnson
- Medtronic plc.
- NeuroMetrix, Inc.
- Omron Corporation
- Philips Electronics
- Samsung Electronics Co., Ltd
- Sonova
- Sotera Wireless
- Vital Connect
- Zephyr Technology Corporation

Read the full report: https://www.reportlinker.com/p06032911/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Smart Medical Devices - Global Key Competitors Percentage
Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Smart
Medical Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 2: World 8-Year Perspective for Smart Medical Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2023 & 2030

Table 3: World Recent Past, Current & Future Analysis for
Diagnostics & Monitoring Devices by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 4: World 8-Year Perspective for Diagnostics & Monitoring
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030

Table 5: World Recent Past, Current & Future Analysis for
Therapeutic Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 6: World 8-Year Perspective for Therapeutic Devices by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Online by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 8: World 8-Year Perspective for Online by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 9: World Recent Past, Current & Future Analysis for
Pharmacies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 10: World 8-Year Perspective for Pharmacies by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2023 & 2030

Table 11: World Recent Past, Current & Future Analysis for
Other Distribution Channels by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2022 through 2030 and % CAGR

Table 12: World 8-Year Perspective for Other Distribution
Channels by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2023 & 2030

Table 13: World Smart Medical Devices Market Analysis of Annual
Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2023 (E)
Table 14: USA Recent Past, Current & Future Analysis for Smart
Medical Devices by Product - Diagnostics & Monitoring Devices
and Therapeutic Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 15: USA 8-Year Perspective for Smart Medical Devices by
Product - Percentage Breakdown of Value Sales for Diagnostics &
Monitoring Devices and Therapeutic Devices for the Years 2023 &
2030

Table 16: USA Recent Past, Current & Future Analysis for Smart
Medical Devices by Distribution Channel - Online, Pharmacies
and Other Distribution Channels - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 17: USA 8-Year Perspective for Smart Medical Devices by
Distribution Channel - Percentage Breakdown of Value Sales for
Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

CANADA
Table 18: Canada Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 19: Canada 8-Year Perspective for Smart Medical Devices
by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 20: Canada Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 21: Canada 8-Year Perspective for Smart Medical Devices
by Distribution Channel - Percentage Breakdown of Value Sales
for Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

JAPAN
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2023 (E)
Table 22: Japan Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 23: Japan 8-Year Perspective for Smart Medical Devices by
Product - Percentage Breakdown of Value Sales for Diagnostics &
Monitoring Devices and Therapeutic Devices for the Years 2023 &
2030

Table 24: Japan Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 25: Japan 8-Year Perspective for Smart Medical Devices by
Distribution Channel - Percentage Breakdown of Value Sales for
Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

CHINA
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2023 (E)
Table 26: China Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 27: China 8-Year Perspective for Smart Medical Devices by
Product - Percentage Breakdown of Value Sales for Diagnostics &
Monitoring Devices and Therapeutic Devices for the Years 2023 &
2030

Table 28: China Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 29: China 8-Year Perspective for Smart Medical Devices by
Distribution Channel - Percentage Breakdown of Value Sales for
Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

EUROPE
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2023 (E)
Table 30: Europe Recent Past, Current & Future Analysis for
Smart Medical Devices by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2022 through 2030 and %
CAGR

Table 31: Europe 8-Year Perspective for Smart Medical Devices
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2023 & 2030

Table 32: Europe Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 33: Europe 8-Year Perspective for Smart Medical Devices
by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 34: Europe Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 35: Europe 8-Year Perspective for Smart Medical Devices
by Distribution Channel - Percentage Breakdown of Value Sales
for Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

FRANCE
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2023 (E)
Table 36: France Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 37: France 8-Year Perspective for Smart Medical Devices
by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 38: France Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 39: France 8-Year Perspective for Smart Medical Devices
by Distribution Channel - Percentage Breakdown of Value Sales
for Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

GERMANY
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2023 (E)
Table 40: Germany Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 41: Germany 8-Year Perspective for Smart Medical Devices
by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 42: Germany Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 43: Germany 8-Year Perspective for Smart Medical Devices
by Distribution Channel - Percentage Breakdown of Value Sales
for Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

ITALY
Table 44: Italy Recent Past, Current & Future Analysis for
Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 45: Italy 8-Year Perspective for Smart Medical Devices by
Product - Percentage Breakdown of Value Sales for Diagnostics &
Monitoring Devices and Therapeutic Devices for the Years 2023 &
2030

Table 46: Italy Recent Past, Current & Future Analysis for
Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 47: Italy 8-Year Perspective for Smart Medical Devices by
Distribution Channel - Percentage Breakdown of Value Sales for
Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

UNITED KINGDOM
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2023 (E)
Table 48: UK Recent Past, Current & Future Analysis for Smart
Medical Devices by Product - Diagnostics & Monitoring Devices
and Therapeutic Devices - Independent Analysis of Annual Sales
in US$ Million for the Years 2022 through 2030 and % CAGR

Table 49: UK 8-Year Perspective for Smart Medical Devices by
Product - Percentage Breakdown of Value Sales for Diagnostics &
Monitoring Devices and Therapeutic Devices for the Years 2023 &
2030

Table 50: UK Recent Past, Current & Future Analysis for Smart
Medical Devices by Distribution Channel - Online, Pharmacies
and Other Distribution Channels - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 51: UK 8-Year Perspective for Smart Medical Devices by
Distribution Channel - Percentage Breakdown of Value Sales for
Online, Pharmacies and Other Distribution Channels for the
Years 2023 & 2030

REST OF EUROPE
Table 52: Rest of Europe Recent Past, Current & Future Analysis
for Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 53: Rest of Europe 8-Year Perspective for Smart Medical
Devices by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 54: Rest of Europe Recent Past, Current & Future Analysis
for Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 55: Rest of Europe 8-Year Perspective for Smart Medical
Devices by Distribution Channel - Percentage Breakdown of Value
Sales for Online, Pharmacies and Other Distribution Channels
for the Years 2023 & 2030

ASIA-PACIFIC
Smart Medical Devices Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2023 (E)
Table 56: Asia-Pacific Recent Past, Current & Future Analysis
for Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 57: Asia-Pacific 8-Year Perspective for Smart Medical
Devices by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 58: Asia-Pacific Recent Past, Current & Future Analysis
for Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 59: Asia-Pacific 8-Year Perspective for Smart Medical
Devices by Distribution Channel - Percentage Breakdown of Value
Sales for Online, Pharmacies and Other Distribution Channels
for the Years 2023 & 2030

REST OF WORLD
Table 60: Rest of World Recent Past, Current & Future Analysis
for Smart Medical Devices by Product - Diagnostics & Monitoring
Devices and Therapeutic Devices - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR

Table 61: Rest of World 8-Year Perspective for Smart Medical
Devices by Product - Percentage Breakdown of Value Sales for
Diagnostics & Monitoring Devices and Therapeutic Devices for
the Years 2023 & 2030

Table 62: Rest of World Recent Past, Current & Future Analysis
for Smart Medical Devices by Distribution Channel - Online,
Pharmacies and Other Distribution Channels - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR

Table 63: Rest of World 8-Year Perspective for Smart Medical
Devices by Distribution Channel - Percentage Breakdown of Value
Sales for Online, Pharmacies and Other Distribution Channels
for the Years 2023 & 2030

IV. COMPETITION
Read the full report: https://www.reportlinker.com/p06032911/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Title:

Content: Will the United States introduce a bill to limit drug prices, and can China solve the problem of "difficult access to medical care"?
Author: Ye Qi
Published: Updated:
One of the ills of the U.S. health care system is high drug prices, but it seems to be getting light these days when the House of Representatives has taken the lead in passing the $1.75 trillion Build Back Better Act.
In the area of health care, the bill proposes that the government can intervene to negotiate a reduction in the price of prescription drugs, so that American drug manufacturers will face the largest drug price regulation in decades.
Essentially, one of the purposes of the Rebuilding a Better Future Act is for the United States to try to solve the problem of “difficulty in seeing a doctor. ”
In fact, the “difficulty of seeing a doctor ” has also troubled the Chinese people. The Chinese government has done a lot of research on the“ difficulty of seeing a doctor ” in the field of medical reform in recent years, and it may be worth learning from.
Solving the difficulty of "seeing a doctor": drug price
In summary, at the State Council's policy briefing in July this year, Li Bin, deputy director of the National Health and Health Commission and deputy director of the Secretariat of the State Council's medical reform leadership group, introduced the key tasks of deepening the reform of the medical and health system in 2021.
Li Bin said that China continues to push to change the focus on medical treatment to focus on people's health, and strive to solve the problems of "difficult to see a doctor" and "expensive to see a doctor".
For many people, high drug prices are the most difficult part of the difficulty of seeing a doctor. (Visual China)
Back in 2012, the Chinese government piloted medical reform in Sanming, Fujian, when its local health insurance fund was facing the risk of “bottoming out ”.
The first goal of "Sanming Medical Reform" is the false high price of drugs and consumables.
The data show that from 2012 to 2020, the total cost of medical care in Sanming city was relatively saved by 11.068 billion yuan (the same below), and the cost of medical supplies was relatively saved by 12.403 billion yuan.
In March 2017, the Central Leading Group for the Comprehensive Deepening of Reform held a meeting, which clearly pointed out that the direction of "Sanming medical reform" is correct and the results are obvious, and we should pay attention to promotion. Dalian, Xiamen, Guangzhou, Shenzhen, Chengdu, Xi 'an.
The above-mentioned cities will form a procurement alliance, and select generic generic generic generic generic varieties that are partially evaluated by quality and efficacy consistency for volume procurement.
"Purchasing with volume" becomes a way to save money
The first national organization of centralized procurement of drugs was a great success, and compared with the lowest purchase price of the same drug in the pilot city in 2017, the proposed price fell by an average of 52% and a maximum of 96%.
Today, the national organization of centralized procurement of drugs has been the sixth batch, the latest special procurement of insulin for diabetic patients.
The procurement demand of national medical institutions in the first year is about 210 million units, and the amount of procurement involved in advance is about 17 billion yuan. The average price of the selected products is reduced by 48%, and the cost is expected to be reduced by 9 billion yuan per year.
Take the clinically commonly used glycine insulin as an example, from an average of 180 yuan per bottle to about 70 yuan per bottle, which can save about 4000 yuan per patient per year.
In fact, in addition to centralized procurement, the Chinese government has also restricted drug prices by establishing a national medical insurance catalog.
The latest 2021 national medical insurance drug catalog adjustment work has been successfully completed recently, a total of 74 drugs have been added to the catalog, and 11 drugs have been recalled from the catalog.
This adjustment involves 94 kinds of national medical insurance negotiation drugs, of which 67 are newly included in the list of negotiated drugs, through the medical insurance negotiation average price reduction of 61.71%, the highest decline of 93.97%.
Coronary arterial stents are purchased with concentrated volume, resulting in significant price reductions and amazing results. (Vision China)
Centralized procurement is not only limited to pharmaceuticals, but also high-value medical consumables. One famous example is the first high-value medical consumables coronary stent centralized procurement in 2020.
Since then, the price of the heart stent has fallen from an average price of about 13,000 yuan to only about 700 yuan. Compared with 2019, the average price of the same products of the same enterprises has fallen by as much as 93%, the average price of domestic products has fallen by 92%, and the average price of imported products has fallen by 95%.
The second centralized procurement of high-value medical consumables is artificial joints, the final product price from an average of 30,000 yuan to less than 10,000 yuan, a decline of more than 80%.
Among them, the average price of the first replacement artificial hip decreased from 35,000 yuan to about 7,000 yuan, and the average price of the first replacement artificial knee decreased from 32,000 yuan to about 5,000 yuan, with an average price reduction of 82%.
Another problem to solve: medical insurance.
According to the latest National Medical Insurance Development Statistics Bulletin released in June 2021, a total of 1.36131 billion people participated in the national basic medical insurance in 2020, and the participation rate is stable at more than 95%. In 2020, the national basic medical insurance fund, including maternity insurance, has a total income of 2.4846 trillion yuan and a total expenditure of 2.1032 trillion yuan. The accumulated personal account balance of basic medical insurance is 1.0096 trillion yuan.
One of the difficulties in health insurance in the Mainland is “visiting a doctor from another place ”. (Visual China)
Health insurance has a lot of seemingly beautiful numbers, but the difficulties behind it are also worth paying attention to. One of them is "medical treatment in other places", which is different due to the financial strength of local governments.
However, since this year, the National Medical Insurance Bureau, the Ministry of Finance and other departments have worked hard to promote the cross-provincial settlement of medical insurance.
As of the end of October, the country has launched the cross-provincial direct settlement service for general outpatient expenses, and has networked 433 co-ordination areas, and at least one designated medical institution in 2,622 cities can carry out outpatient cross-provincial and off-site settlement.
Tackling the third difficulty: local drug research and development
According to reports, the mainland has implemented major new drug innovation as early as 2008, in order to guide and support local innovation.
Chen Kaixian, an academician of the Chinese Academy of Sciences, said at a public event in 2020 that in the past 10 years, the central government has invested nearly 20 billion yuan to support the innovation and development of biopharmaceutical in China, of which more than half of the investment in innovative drugs has been approved.
Financial support for national vaccines
China ’ s support for local drug development is strong, and one of the most obvious examples is the COVID-19 vaccine.
When Chinese companies develop COVID-19 vaccines, the funds will inevitably receive financial support from the central or local governments.
The Ministry of Finance has issued a notice, which clearly requires local financial departments at all levels to increase financial support, fully cooperate with relevant departments to allocate funds in a timely manner, and effectively protect the funding needs of scientific research such as vaccines.
A clear example of China ’ s strong support for local drug development.
(Visual China)
As early as the outbreak of the new coronavirus epidemic at the beginning of last year, the central enterprises and state-owned pharmaceutical companies have arranged up to 1 billion yuan in research and development funds and obtained an emergency project from the Ministry of Science and Technology.
Yang Xiaoming, chairman of Sinopharm China Bio, revealed that in the development of inactivated vaccine research and development process has been strongly supported by the state, including the National Drug Administration for vaccine research and development institutions to open green channels, in the past need to complete the declaration materials, one-time submission, into a part can be prepared, submitted, and the State Drug Administration and synchronously audit to improve the speed of approval.
In the end, Sinopharm ’ s vaccine successfully broke the norm of “10 billion years ” and entered clinical trials in only 98 days, was put into emergency use in 177 days, and was officially listed in 335 days.
The United States is taking the first step in solving the problem of medical care.
Since the Chinese government proposed “Healthy China ” in October 2009, China ’ s medical reform process has been more than 10 years, and the results have been remarkable. Especially in recent years, there have been drastic policies to limit drug prices.
However, as the National Medical Insurance Bureau has admitted, the current development of China's medical protection is still uneven and inadequate, "multi-level medical protection system is not perfect, medical insurance, medical and pharmaceutical reform coordination needs to be further strengthened", which shows that medical reform is a more important task.
Looking back at the "Rebuilding a Better Future Act" in the United States, although limiting drug prices is only the first step, there are many thorny problems such as "sky-high" treatment costs and lack of basic medical protection for the entire population.
But in any case, the first step is always good, and the bill will at least gradually reduce the financial burden of the elderly and other long-term patients, and more importantly, reflect the government ’ s real efforts to gradually correct the “difficulty of seeing a doctor. ”

Title:

Content: DAYTON, Ohio (WDTN) – With Christmas fast-approaching, families have a new item on their shopping list: flu medication, and the surge in cases is making that more difficult to find.

With the level of illness spreading in the community, Cedar Care Village Pharmacy Director Justin Coby said it could indicate we are headed toward a drug shortage.

“It is common supply and demand,” Coby said. “The demand is high. Flu rates are the worst they’ve been in over a decade.”

Whether you or your children need medication to manage flu symptoms, or antibiotics for an infection, these medications might be hard to find right now.

“You’re going to see folks struggling to find those products staying on the shelves because of how aggressive this influenza season is,” Coby said.

2 NEWS reporter Allison Gens walked through several stores in the Miami Valley Friday to look at the supply of medicines and saw empty spaces on the shelves, and even a sign telling customers they’re experiencing supplier shortages.

Coby said both prescription and over-the-counter medications are in short supply right now, and there are a number of factors, including two slow flu seasons prior.

“We knew it was going to be a bad season, but if you think about it, from the time to manufacture through the supply chain to get to the end user, they would have had to have known that for a long time,” Coby said.

Coby recommends calling around to different stores and local pharmacies to see what’s in stock.

If you cannot find the medicine you need, contact your doctor about the options you have to manage symptoms at home.

Dr. Jordan Knox, family physician with Kettering Health Springfield, said the key is plenty of rest and plenty of water.

“The best thing is to take frequent small sips of water, two teaspoons every three to five minutes,” Knox said. “It really does add up, and it’s easy enough on the stomach.”

Knox said with medicines in short supply, the best step is prevention. He said everyone should be washing their hands, staying home when sick and even wearing a mask when not feeling well.

He also said it’s not too late to get the flu shot.

“With holiday travel, gatherings coming up, if you haven’t already had your influenza vaccination this season, please get one in the next couple of days or as soon as possible,” Knox said.

Flu season typically peaks between December and February, and some experts predict the supply chain issues could continue into early next year.

Title:

Content: In St. Petersburg pharmacies noticed queues.
What do experts say about “stockpiling medicines ”?
Pharmacy chains faced high demand amid news of a sharp weakening of the ruble, logistical disruptions and sanctions against Russia.
5
Share
Retailers, distributors and officials unanimously recommend that citizens do not panic and do not create an artificial deficit.
Stocks will last for six months, prices will increase - no more than 25%.
Sanctions are not threatened with drugs, and if necessary, European and American drugs are ready to import substitute domestic pharma.
It is true that we will have to sacrifice the rules of patent law.
The fact that residents of St. Petersburg rushed to buy medicines, reported the participants of the pharmacy market.
So the service "Apteka.ru" warns customers that "due to the increased demand for medicines, there may be an increase in the delivery time of orders."
“There is an increased demand, including for original drugs of import production, ” Olga Lipina, director of the University Pharmacy network, told Fontanka.
Photos with queues in several pharmacies, which appeared in the media and social networks, have already forced Smolny officials to urgently calm the population.
“In our difficult time, it comes to mind that we have a deficit of some kind.
I can say that there is no shortage of medicines, ” said the head of the Committee on Industrial Policy Kirill Soloveichik.
According to him, the queues are associated “exclusively with technical failures in information systems. ”
The lack of a deficit was also stated by the commissar.
For beneficiaries, the city bought medicines for six months, and for some positions and for a year in advance.
"This applies to drugs for the treatment of oncological and oncohematological diseases, diabetes, bronchial asthma, mental diseases, other diseases, as well as medical products - test strips to determine the level of glucose in the blood," - said on the page of the Ministry of "Vkontakte" .Refusals suppliers from entering into contracts, and the supply of drugs under the contracts are carried out in a timely manner, noted in the health committee.
The Ministry stressed that the goods from the list of vital (788 items) will not rise in price precisely, since prices are controlled by the state.
Retailers and manufacturers confirm that the drugs in the warehouses will last for a long time.
According to Olga Lipina, no one was ready for increased demand, so some positions may temporarily disappear from the range of pharmacies.
“You don ’ t have time to work out all the logistics, ” she says.
Suppliers also send calming letters to networks, urging them not to make purchases over the norm.
Stocks of drugs in the warehouses of manufacturers and distributors will last from 4 to 6 months, says Nikolai Bespalov, development director of the analytical company RNC Pharma.
But if people continue to panic, semi-annual volumes can be bought much faster, he said, and “this is not a very correct strategy, the hype only aggravates the situation. ”
He also recalled that the shelf life of drugs is about 2 years and it is necessary to soberly assess your need so that later expired tablets do not have to be thrown out.
The Association of Independent Pharmacies does not expect any interruptions in supplies.
“We are doing everything possible to prevent a deficit in one or another position.
Overall, the situation is stable.
Stocks of drugs have been created both in pharmacies and at suppliers, ” said Victoria Presnyakova, director of the association.
But the situation with prices is not so favorable.
The share of imported medicines in the Russian market is 56.3% in money and 31.4% in packages, the research company DSM Group reported in a report for 2020.
In addition, foreign pharmaceutical substances are used in the production of domestic medicines.
According to Olga Lipina, the price increase is already underway.
Medicines from the list of vital added to suppliers up to 5% of the cost, original or rare drugs - up to 10%.
“The exchange rate difference has not yet been won back, ” admits the top manager.
Against the background of the weakening of the ruble, suppliers increased prices from 2 to 25%, for some positions - up to 40%.
The same growth they will show in retail, says Victoria Presnyakova.
The network “PetroApteka ”, at the points of which on the Petrograd side and noticed the queue, warns that on its website“ technical work is being carried out, as a result of which prices may be displayed incorrectly. ”
According to Nikolai Bespalov, pharmacy chains face a temporary suspension of shipments, as well as the abolition of deferred payments or shares from distributors.
“Now we are talking about the growth of prices in the range of 20-25%, ” the expert estimates.
But it ’ s not enough to cause panic, he said.
In addition to short-term risks, there are long-term risks.
The total volume of imports of finished drugs to Russia in 2021 reached 787.4 billion rubles, according to RNC Pharma.
A total of 1.82 billion were imported.
Deliveries in bulk (unpackaged products) - another 166.4 billion rubles.
According to DSM Group, the highest share of imported drugs in medicines for rare diseases, which the state purchases for beneficiaries (programs “14 nosologies ”, ONLS, RLS) - 63% in monetary terms.
Moreover, imported drugs are considered to be domestic, whose production is localized in Russia.
On the one hand, drug provision has never been subject to sanctions, says Nikolai Bespalov.
On the other hand, market participants began to experience problems with logistics.
“There are precedents when on the territory of Poland trucks that went to Russia were stopped and looted.
Logists are in an alarming state, ” says Nikolai Bespalov.
According to him, the search for bypass routes and the demand for additional financial guarantees also provokes an increase in prices.
Logistics is dead.
Everything that comes from Southeast Asia has slowed down, everything that comes from Europe is on the border of Poland and Germany, ” said Dmitry Borisov, director of Polisan.
According to him, stocks of raw materials will last for six months.
Now the company is switching to the products of Russian suppliers, as well as China and India.
The collapse of the ruble will hit the profitability of production, but so far will not affect the price, since Polisan produces drugs from the list of vital, and the adjustment for them occurs once a year.
But in Russia, there were precedents when pharmaceutical companies refused to produce drugs if the price of the drug included in the list of VED, with difficulty covered the cost of its production.
According to Nikolai Bespalov, most of the drugs that are imported can be replaced by Russian companies.
“If you sacrifice the norms of patent law, you can talk about 95-98% of the total, ” he says.
But the launch of its production and the reorientation of logistics to the Asian region will take time.
“I hope that we consider this scenario as hypothetical, ” the expert comments.
China and India already supply 75% of the substances: “These two directions and half of what comes from Europe will be easily replaced. ”
At the same time, Bespalov admits that there are “irreplaceable positions ”.
Earlier, Dmitry Borisov in an interview with Vedomosti noted that the violation of patent rights for drugs threatens to turn Russia into a “banana republic ”: without real competition, the country will produce“ century-old generics ” when the rest of the world goes forward, he explained.
The manufacturer of insulins Geropharm does not experience difficulties with the supply of substances.
“To date, the production of drugs is carried out in the usual mode, ” says General Director Peter Rodionov.
But the top manager did not rule out that “due to the current situation in the future, difficulties may arise due to rising prices, difficulties with logistics. ”
Galina Boyarkova,
"Fontanka.ru"
SHARE
JOIN NOW
The most vivid photos and videos of the day are in our groups in social networks. Join now:
Did you see the typo?
Select a fragment and press Ctrl + Enter
Comments (5)
It is time to learn how to make iodine (honey, who did not understand).
That's enough.
We'll stock up on our own.
For wealthy citizens will always be available Vietnamese balm "Star".
It helps from everything - from the interior kidney, to the skin rash with migraine.
"True, you will have to sacrifice the norms of patent law." (citation)
It's not about patent law, quality will be sacrificed, that's what's scary...
The fact that there is and will not be a deficit - there is no doubt about it.
Another thing is that due to the growth of the dollar by 40% or more, prices will eventually rise by exactly the same amount.
Therefore, buying today at a cheaper price is quite a reasonable move.
And there will really be no shortage, they will bring you at a new price as much as you want.
Our partners
Lentainform
Loading...

Title:

Content: General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
General Supervision
Elham Aboul Fath
Editor-in-Chief
Thank you for your patience.
Despite the availability of the dollar...
Parliamentary action on the suffering of people with chronic diseases due to the lack of treatment
Dr. Hisham Hussein, Secretary of the Suggestions and Complaints Committee of the House of Representatives, submitted a request for a briefing to Advisor Dr. Hanafi Jebali, President of the Council, addressed to the Prime Minister and Minister of Health and Population, on the continued shortage of medicines and medical supplies, despite the availability of the dollar, and the impact of this on people with chronic diseases.
Hisham Hussein pointed out that the past few days have witnessed a great problem in the insufficiency of intensive care beds and emergency departments in hospitals, due to the frequency of critical cases, which were unable to get the necessary treatment on the scheduled dates.
Hisham Hussein explained that many people with chronic diseases such as heart, kidney, tumors, diabetes and others delayed the payment of their scheduled treatment, whether from health insurance, or treatment at the expense of the state, which caused complications that led to their need to enter hospitals in emergency departments or non-intensive care.
The MP stressed that because of the heavy pressure on hospitals, many cases were unable to get the necessary treatment, which led to many complications and portends a great problem.
The member of the House of Representatives pointed out that many have pinned their hopes on the availability of the dollar in the past period, to meet the needs of the medical sector of medicines and supplies, saying: However, it seems that more action is needed in this regard.
Hisham Hussein called on the Ministry of Health, in coordination with the concerned authorities, to take the necessary measures to provide all medicines and medical supplies for the benefit of chronic diseases, by reviewing all needs, stressing the need to facilitate procedures to obtain medicines through health insurance or treatment at the expense of the state.

Title:

Content: Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
I'm sorry.
My grandfather, Zainuddin.
Chairman of Wafd Party
Dr. Abdul Sindh Yamama
Chairman of the Board of Directors
Dr. Ayman is an accountant.
Editor-in-Chief
I'm sorry.
My grandfather, Zainuddin.
Insulin, antibiotics and pressurized drugs top the list
Massive shortage of all chronic diseases drugs in Dakahlia pharmacies
Despite the announcement of increases in the prices of medicines, there is a severe shortage in Dawiya in Dakahlia governorate, which is one of the most consuming provinces of medicines due to its high population density.
Featured Medicines
The most prominent drugs that are in shortage in Dakahlia province is a long list, foremost of which are insulin drugs for diabetics, then all low pressure drugs of all kinds, whether tablets or drops, as well as solutions and important rheumatism drugs, along with all types of antibiotics and alternatives.
Diabetic disease
Abdul Rauf Ghanem says that he has been suffering from diabetes for years and was surprised several months ago by the disappearance of insulin, which caused his bad condition, as well as his daily suffering to search for it in all pharmacies without success, pointing out that the major pharmacies also disappeared insulin, what to do and who intervenes to end our suffering.
Liver Medications
Ahmed Mohammed Sadek adds that everyone knows that there is a coming increase in the prices of medicines, so what is the justification for the disappearance of medicines from pharmacies as long as prices will be increased?
He pointed out that he is one of the liver patients and has been searching for the necessary albumin for treatment for a whole week without success, and calls for the rapid provision of drugs, especially for patients with chronic diseases until this nightmare ends soon.
Disappearing Alternatives
Mr. Ibrahim confirms that the dentist prescribed him an antibiotic to treat infections in the teeth and searched for it in all pharmacies in vain, adding that he asked the pharmacist to bring an alternative, but the alternative unfortunately was not available as well, pointing out that patients are currently living difficult days as a result of the lack of availability of vital drugs.

Title:

Content: Staff burnout in healthcare is growing. Can AI help ease the burden?

เม.ย. 26, 2565 - Reading time 4-6 minutes

After a prolonged battle with the COVID-19 pandemic, healthcare providers now face the next crisis that has been brewing even longer: staff shortages and an increasingly exhausted workforce. In early 2022, almost one in two (47%) healthcare professionals reported feeling burned out, up from 42% last year [1]. Many consider leaving the field, adding to the worries of employers who see growing demand for care without enough hands at the bedside to cater for their patients [2]. Can AI be part of the solution by helping healthcare professionals reclaim the joy in their work?

The signs of a pending burnout crisis were already there before COVID-19 wreaked havoc with health systems worldwide. And the causes run deeper than the stress inflicted by the pandemic. In many ways, the past two years have magnified what was ailing healthcare professionals all along: the draining repetitiveness of routine tasks, a growing deluge of data that leaves them scrambling for relevant insights, and widespread frustration about workflow inefficiencies that get in the way of attending to patients. As one physician expressed in the 2022 Medscape Physician Burnout and Depression survey: "Where’s the relationships with patients that used to make this worthwhile?" [3].

Healthcare providers face exodus of staff

It should come as no surprise, then, that healthcare has been among the top three industries impacted by the Great Resignation, with many healthcare professionals quitting their positions to find improved work-life balance [4]. And for healthcare organizations facing increased turnover, the worst may be yet to come. According to a new study by the American Medical Association, one in five physicians and two in five nurses intend to leave their current practice within the next two years [5].

As a result, staff shortages are now the number one concern keeping American hospital executives up at night [6]. Other countries around the world – from the UK and Germany to Singapore and Australia – are seeing a similar exodus of healthcare professionals, fueling fears about the potential impact on quality of care [7,8,9,10].

Simplifying workflows through AI-based automation

What we’re witnessing is an increased urgency to liberate healthcare professionals from the strain of tedious and repetitive tasks, so that they can focus on what drew them to medicine in the first place: caring for patients. It’s exactly what AI can help to make possible. By shifting the burden of tedious manual work from human to machine, AI allows healthcare professionals to apply their time and energy to the patient rather than to cumbersome processes.

Take medical imaging technologists, for example. Ranked #2 by hospital CEOs as the profession that is seeing the largest shortage of qualified staff [11], technologists have the daily challenge of achieving best-quality, first-time-right scans, with high workloads being the #1 contributor to job-related stress [12]. Patients are often anxious, too, which adds to the pressure on technologists to get the exam done effectively. Variability in training and experience levels of staff can further impact outcomes.

By automating many of the time-consuming tasks that technologists traditionally had to perform manually, we can free up their focus to interact with the patient, while improving consistency of results at the same time. Research shows that imaging staff welcome such support from technology – they believe that almost a quarter (23%) of their work is inefficient and could be automated [13].

Getting the patient in the right position for an exam is a case in point. In an imaging modality like CT, patient mispositioning is a common challenge, with unwanted consequences such as increased radiation dose to the patient or image noise [14]. That’s where new AI-enabled camera technology can make a difference. Mounted on the ceiling above the patient table, the camera uses algorithms that can automatically detect anatomical landmarks in the patient, supporting fast, accurate and consistent patient positioning.

Smart and touchless patient sensing technology is also saving technologists manual work in MR imaging, where it can automatically monitor a patient’s breathing – allowing the setup of routine MR exams to occur in less than a minute [15], even for less experienced operators, while helping them keep a caring eye on the patient. In addition, smart AI-enabled systems can suggest the most appropriate protocol for each MR exam, as well as automate exam planning, scanning, and processing.

Thanks to such AI-based automation, technologists have to worry less about equipment settings and can dedicate more attention to the patient, making their work less stressful and more rewarding.

Providing relevant insights at scale at the point of care

In the face of growing information overload, AI can also ease the burden on healthcare professionals by supporting them with relevant insights at the point of care.

For example, one of the biggest challenges facing critical care teams in intensive care units (ICUs) is the sheer volume of data collected on every patient. Each patient in the ICU may generate up to thousands of data points per day, leaving physicians and nurses feeling overwhelmed as they struggle to separate signal from noise [16].

Using predictive analytics, we can help critical care teams cut through the clutter by alerting them to relevant trends in patient data that call for urgent intervention, or which may indicate that a patient is ready to be transferred to a lower-acuity setting. The physician or nurse remains in control of all decisions. But with the support of AI, they may be able to make these decisions more easily.

In the future, AI-enabled patient monitoring solutions will increasingly be extended from the hospital into the home, allowing healthcare providers to keep a caring eye on patients and thereby prevent avoidable hospital (re)admissions. This could alleviate some of the pressure on overstretched emergency and critical care teams, while also giving patients greater peace of mind in the comfort of their homes.

The need for human-centered AI

Of course, technology can only be one part of effective staff retention and burnout mitigation strategies. But as these and other examples demonstrate, AI could go a long way towards enhancing the human experience in healthcare – both by improving workflow efficiencies and by augmenting clinical expertise.

Most importantly, to curb burnout and revive the joy in medicine, we need to ask how we can develop digital tools that support the patient-provider relationship rather than get in the way of it. Studies have consistently shown that lack of workflow integration is one of the main barriers to wider adoption of AI in healthcare, pointing to a need for human-centered design.

By putting people front and center, we can develop AI-based solutions that act as an unobtrusive assistant, supporting healthcare professionals at a time when they are under more pressure than ever before. Because if there’s one truth that the growing staffing and burnout crisis in healthcare is bringing to the fore, it’s that there is no healthcare without healthy and engaged healthcare professionals.

References
[1] https://www.medscape.com/viewarticle/966996
[2] https://www.sciencedirect.com/science/article/pii/S2542454821001260
[3] https://www.medscape.com/viewarticle/966996
[4] https://www.bls.gov/news.release/jolts.nr0.htm
[5] https://www.sciencedirect.com/science/article/pii/S2542454821001260
[6] https://healthexec.com/topics/healthcare-administration/hospital-ceos-workforce-shortages-challenging
[7] https://www.theguardian.com/society/2022/feb/26/stressed-nhs-staff-quit-at-record-rate-of-400-a-week-fuelling-fears-over-care-quality
[8] https://www.iamexpat.de/career/employment-news/germanys-shortage-nursing-staff-continues-worsen
[9] https://www.smh.com.au/national/pandemic-triggers-mass-exodus-of-critical-care-nurses-20211116-p5998i.html
[10] https://www.straitstimes.com/singapore/politics/more-healthcare-workers-in-spore-resigning-amid-growing-fatigue-as-covid-19-drags
[11] https://healthexec.com/topics/healthcare-administration/hospital-ceos-workforce-shortages-challenging
[12] https://www.usa.philips.com/healthcare/medical-specialties/radiology/improving-radiology-staff-and-patient-experience/staff-research
[13] https://www.usa.philips.com/healthcare/medical-specialties/radiology/improving-radiology-staff-and-patient-experience/staff-research
[14] Habibzadeh MA, Ay MR, Asl AR, Ghadiri H, Zaidi H. Impact of miscentering on patient dose and image noise in x-ray CT imaging: phantom and clinical studies. Phys Med. 2012;28(3):191-199. http://doi:10.1016/j.ejmp.2011.06.002
[15] Based on in-house testing. Results may vary.
[16] https://hbr.org/2018/03/how-mayo-clinic-is-combating-information-overload-in-critical-care-units

You are about to visit a Philips global content page

You are about to visit the Philips USA website.

ไซต์ของเราสามารถดูได้ดีที่สุดด้วย Microsoft Edge, Google Chrome หรือ Firefox เวอร์ชันล่าสุด

Title:

Content: December 15, 2022
15 December 2022 ° C
50 medicines missing in Algeria, rare reasons
+ - 0 Read
President of the National Union of Private Pharmacists, Massoud Belambri, revealed that about 50 pharmaceutical brands are missing in Algeria, expressing regret that the regulation of the pharmaceutical market in Algeria has not been reached, despite efforts, legal reforms, inspection, control and reporting.
He explained that the scarcity of medicines is due to internal and external reasons, as the international market recorded a scarcity of medicines, such as paracetamol and amoxicillin, due to the scarcity of raw materials (which are included in medicines) and their high prices, and the countries producing raw materials give priority to their local market.
At the national level, the same speaker explained that the scarcity of medicines is linked to some legal texts that are not in line with the market, and the behavior of some drug distributors who "have turned into large wholesalers and suppliers of other distributors, and this behavior caused a great disruption in the distribution of medicines.
The radio guest called on the concerned authorities to take measures to avoid aggravating the situation.
By reviewing the prices of some drugs to ensure their availability and continued manufacture on the market.
He stressed that there is a fluctuation in the availability of insulin (despite the import of quantities of it, but the suffering has continued for more than a year.
On the other hand, the President of the Syndicate was surprised by the withdrawal of medicines from the national market and despite the publication of this list, doctors still prescribe them in the prescriptions, and here it must be pointed out the importance of coordination, communication and updating information.
Share your opinion

Title:

Content: Gazeta.ru on desktop
for quick access
Install
Not now
Financial Times: The European Union has decided to create a strategic supply of scarce drugs
The European Union (EU) intends to create a strategic supply of medicines and oblige manufacturers to guarantee their supply.
This is reported by the Financial Times with reference to the representative of the European Commission (EC).
According to the interlocutor of the publication, the shortage of pharmaceuticals is a “systemic challenge ” for EU member states, so the EC intends to ensure“ strategic autonomy ” in the supply of essential drugs, such as paracetamol and penicillin.
The FT source also said that in the near future the European Commission will introduce a law that will allow “to ensure access of all patients in need to medicines. ”
For this purpose, it is planned to “introduce stricter obligations for suppliers, improve the availability of information on drug stocks, and require earlier notification of shortages. ”
According to the European Commissioner for Health Stella Kyriakidis, discussion of these measures with representatives of the industry has already taken place.
Earlier it was reported that the French authorities banned the online sale of paracetamol until the end of January 2023 due to problems with the supply of the drug.
According to a press release from the French government, the tense situation with the supply of drugs based on paracetamol persists in France for more than six months.
This also applies to drugs intended for children.
Share:
Downloading
Found a bug?
Close

Title:

Content: 09: 33, 03 September 2021
In Russia, there was a shortage of a vital medicine for childhood epilepsy
In Russia, there was a shortage of a vital medicine for childhood epilepsy, – writes the newspaper RBC.
Two charitable foundations have drawn attention to the problem.
In addition, parents complain about the lack of a number of drugs, including those that do not have registration in the country.
At the same time, doctors warn that replacing one drug with any analogue or suspending its intake threatens to worsen the condition of the child.
The Ministry of Industry assured that now they are taking the necessary measures for the prompt import of the drug.
They explained the interruptions in the delay in the re-registration of this funds.
Uploading comments...
The most discussed
Popular for the week
On the air today

These shortages stem from various causes, including supply chain disruptions, demand spikes, and manufacturing delays.

Title:

Content: Through creative outputs that look forward to the future
Government Summit Accelerates Digital Transformation of Healthcare Systems
T + T - normal size
The summit will discuss health topics this year, including the future of communities and healthcare, which addresses the impact of globalization on virtual communities, and the importance of addressing issues related to work ethics and behavior and addressing the state of global health systems, ensuring mental health and analyzing future developments.
Big boom.
The health sector in the UAE has witnessed a great leap in line with the latest advances in medicine, science and human knowledge at the global level, along with the provision of smart and specialized medical services harnessing technology, and health services based on modern medical sciences, such as genomics and nanotechnology.
The next phase will witness rapid development and growth of the future of health care and medical services to anticipate and keep pace with changes in the health field, through a package of innovative projects in the private health sector, most of which are based on next-generation technologies of the fourth industrial revolution and artificial intelligence, with a focus on preventive health care and smart services around the clock without human intervention.
The changes in healthcare systems in the country have shown opportunities to accelerate the digital transformation of primary and community care systems, especially after the COVID-19 crisis was a catalyst for change to digital transformation. at the same time through the management of general economic needs.
Health authorities have recognized the role that technology plays in supporting the realization of this vision, which requires a change in the way of thinking, especially as they go further in this direction, for example, people book appointments online and sometimes ask for medical consultations via video instead of meeting a doctor directly.
Telemedicine
The adoption of digital technology to provide health care services (telemedicine) was considered one of the most important steps during the COVID-19 pandemic, allowing the technology to monitor and care for the patient without the actual intervention of the doctor. From examining vital signs such as blood pressure, blood sugar levels and temperature, the technology allows accurate detection of any deterioration in chronic conditions, without the need to visit the ambulance departments. The transfer of access to health care to places of residence, work and entertainment.
This has resulted in higher levels of comfort and interaction, and therefore remote patient monitoring has improved the level of health services provided.
The benefits of this are not limited to patients who will have higher interaction with health providers, but also to doctors who will be better able to treat their patients ’ health conditions thanks to continuous monitoring of the data they receive, giving them a better picture of the patient ’ s health status.
Digital Transformation
Undoubtedly, the best example of this was the remote monitoring platform in Abu Dhabi, which demonstrated the readiness of the Middle East countries to adopt this trend towards digital transformation and health care from home. The platform allowed patients to renew their prescriptions, especially for those who need to be isolated from the rest of the community due to the sensitivity of their health situation.
This has extended to the development of Saudi Arabia ’ s digital healthcare model, which encompasses services ranging from helping patients self-isolate during the COVID-19 pandemic to receiving medical consultations from home and providing greater communication between medical providers and patients.
More than ever before, the UAE is rapidly using real-time tracking applications for hospital equipment, such as tracking heart monitoring equipment and infusion pumps depending on where the patient is located, which has helped it allocate resources between hospitals more efficiently and has allowed it to track equipment or people.
The WHO Regional Office for the Eastern Mediterranean appreciated the UAE ’ s efforts to transform the health challenges and consequences resulting from the COVID-19 pandemic into real opportunities for digital innovations and support healthcare in the country in new ways and methods that have facilitated access to healthcare services for all patients despite the ban imposed by COVID-19. After.
The report of the regional office explained that e-visits in the UAE in light of the Coronavirus pandemic provided health care for people with chronic diseases, telephone or video consultations, in addition to electronic prescriptions and the delivery of medicines to the home.
Telemedicine is a successful form of healthcare delivery, used in more than 85 countries and territories around the world, and is now available in the UAE and allows patients to talk to doctors and get medical advice over the phone instead of visiting a doctor in a clinic or hospital.
Digital health in the UAE is also using social media to provide people with chronic diseases with information and messages about COVID-19 and their exposure to more severe symptoms due to their circumstances, the importance of avoiding unhealthy behaviors such as tobacco use and unhealthy diets.
Role of data
It is natural that the digital transformation of health care models provides more data, which can be analyzed using artificial intelligence techniques, and the use of technology to collect, analyze and display data related to the case and present it to the doctor, who can in turn perform the appropriate procedure for the patient.
This involves providing easy-to-read and shareable information that helps doctors make better decisions, especially those working under stress, allowing them time to focus on what matters most: optimal patient care.
The Ministry of Health and Prevention, the Department of Health in Abu Dhabi and the Dubai Health Authority announced the completion of the electronic link between the unified national health file, making the UAE the first country in the world to share patient health data between its public and private health facilities, through its platforms « My Care » and Melfi and Nabed.
The number of medical records connected to my care system reached more than 1.9 billion medical records for 9.5 million patients, who can be reached through more than 90,000 health service providers in 3,057 medical facilities connected to the system.
It will allow doctors and healthcare providers across the UAE to easily access patient health information from anywhere in the country, enabling them to provide better patient care.
The integration of the platforms is an important achievement in the healthcare sector, which comes as part of the digital transformation strategy for the healthcare sector to build a sustainable and efficient health system to enable patients to access premium healthcare services.
The integration of RIYATI, MULFI and Nabed platforms is a significant step in improving the health and safety of the UAE community. The UAE ’ s experience in sharing health information has become a model that is appreciated by other health systems in the region. To develop the necessary policies to make the society healthier, and to establish the UAE ’ s distinguished position in digital health globally.
Diversified services
Health authorities confirmed that the use of telemedicine and medical health in the UAE has greatly helped to ensure the continuity of services for people living with non-communicable diseases in the COVID-19 pandemic and data shows that there is an increase in the number of people using the e-visit service and their satisfaction with this service.
It is the duty of health care practitioners to take steps to maintain the confidentiality of personal medical information consistent with patient preferences.
For example, medical discussions between a doctor and a patient should be conducted in a closed format, and the patient may prefer to be contacted by a doctor over a cell phone rather than a fixed home number. Even close family members who are sufficiently aware may not necessarily be allowed to obtain information about the medical condition of a loved one.
All patients are entitled to confidentiality unless they are granted permission to declassify their medical data. A federal law called the Patient Information Protection System applies to most healthcare practitioners and related legislation, known as the Privacy Rules, which sets out detailed rules on privacy, access to information, and disclosure. Corrections should be made if errors are detected.
Healthcare practitioners must routinely disclose their procedures regarding the privacy of personal medical information, healthcare practitioners can share patient medical information among themselves, but only as much as is necessary to provide medical care, and healthcare workers must take appropriate precautions to ensure the confidentiality of their communications with patients.
Mental Health
Modern technology and smart technologies affect people and society, and the impact of modern technology on the mental health of humans is the most important and dangerous, as it is about human health and psychology, technology causes a lot of disorders for some people, so everyone should be careful when dealing with all modern technologies to try to minimize their disadvantages.
Studies and research have shown that the use of technology and social media causes intermittent sleep for many people, negatively affecting mental health, in addition to increasing anxiety, depression and lack of new friendships.
Cons
Excessive use of modern technology causes many health problems. According to some international studies, excessive use of mobile phones, tablets and computers and exposure to radiation prevents the secretion of the hormone responsible for the desire to sleep. Internet addiction is a type of behavioral disorder. This disorder occurs to people who spend a long time using the Internet. Children and adolescents often become addicted to Internet and technology. Therefore, they should not exceed the time allowed to use the Internet.
Print Email

Title:

Content: Healthcare companies moved higher as tech companies continue to enter the space.

Facebook parent Meta Platforms has created a tool to predict the structure of hundreds of millions of proteins using artificial intelligence. Researchers say it promises to deepen scientists' understanding of biology, and perhaps speed the discovery of new drugs.

Meanwhile, a drug used to extend the lives of people with advanced prostate cancer is in short supply and will be for months, leaving some patients with no treatment option as the manufacturer works to ramp up production. The Food and Drug Administration said last week the availability of Pluvicto is limited as manufacturer Novartis struggles to meet demand. The drugmaker said the shortage stems from manufacturing and delivery issues.

Write to Amy Pessetto at amy.pessetto@dowjones.com

(END) Dow Jones Newswires

03-16-23 1727ET

Title:

Content: HI, {{username}}
Manage account
Change password
HEADLINES
{{headlineCount}} new {{headlineCount = = 1?
'update': 'updates'}}
+ MORE HEADLINES
Opportunity to restore drug coverage with $73 million
26.
APRIL
2024.
A
+
A
- Ah!
Print
Email
Email
A
+
A
- Ah!
- Muhammad Wahba.
The Technical Committee of the National Social Security Fund has prepared a scientific study with a financial and social dimension on the out-of-hospital drug bill, and examined the opportunities and costs of re-coverage of the drug at the rates currently in force, i.e. 80% for the majority of drugs, and 95% for a specific section of drugs.
The study concluded with four scenarios, the most prominent of which is that the branch of sickness and maternity insurance will not use more than 35% of its annual revenues, or the equivalent of 6600 billion liras, to finance the coverage of medicine “without compromising the quality of health care provided or the percentage of the contribution approved in the fund ”, i.e. the terms and conditions that were in force before the monetary, banking and economic crisis.
However, if subsidies on medicine are lifted, the cost will rise to 8,200 billion liras, meaning that the Sickness and Maternity Insurance Branch will use 42% of its revenues.
In both cases, this means that the funds are available at the escrow, but directing their use requires the implementation of a clear strategy, rather than the current management confusion and the fragmentation of the board of directors and their reluctance to formulate a strategy to manage the crisis phase and its aftermath according to specific priorities, and financially and socially feasible.
The mere existence of such an option means that the Fund is able to restore coverage to more than 500,000 families with an estimated 1.2 million beneficiaries who pay for the drug from their incomes eroded by continued inflation.
The guarantee is able to play a structural role in health coverage for the insured, and perhaps later for all residents.
This comes after the guarantors lost hope of restoring the margin of safety that was broken when the cost of medicine and hospitalization increased by 43 times, while the Fund showed inaction by doubling the contributions only four times.
Thus, the burden on families deepened, as the exchange rate increased 59 times and food prices increased 233 times, according to the Central Statistical Index (2019-2024).
This guarantee option includes “re-pricing the least expensive drug in each scientific formulation, without compromising the quality of health care provided or the approved contribution to the fund. ”
Note that there are options ranging from re-coverage of categories of medicines, which reduces the cost, or reducing the percentage of the guarantee contribution to cover the drug bill, or combining the available options.
These studies, and the available options, were based on the fact that the contribution of the Guarantee Fund to the out-of-hospital medicine bill cost (average 2013-2018) about 40% of the contributions of the Sickness and Maternity Insurance Branch, equivalent to 300 billion liras per year ($200 million), and the guaranteed share of this expenditure was $350 per year and a quantity of medicine equivalent to 22.6 units (medicine box or equivalent unit).
But after the collapse, the Fund ’ s contribution deteriorated in quantity and quality, mainly due to the deterioration of the exchange rate and the accumulation of transactions of the guarantors to restore the coverage of the medicine, without liquidation in the guarantee offices.
Thus, the contribution of the guarantee decreased to 42 billion liras in 2023 ($0.5 million), and with it, the share of the guarantee decreased from $16 in 2019 to $1 in 2023, and its share of the drug decreased to 0.8 medicine packs.
In fact, what the study does not say is that the guarantee department dealt with reality lightly and irresponsibly.
This is evident in the study of the evolution of drug prices and the evolution of the exchange rate compared with the development of consumer prices, including medicine.
In mid-2016, the contribution of the guarantee to the drug bill began to increase and rose from 283 billion liras to 336 billion liras in 2019.
While this could have been justified by the increase in the number of subscribers to the guarantee from 577 thousand to 606 thousand, but in this period it was noted that the share of the guaranteed amount of the drug was stable between 22.2 cans and 21.8 cans and the per capita expenditure of the guarantee increased from 327 dollars to 370 dollars, an increase of 13.1%.
Here it became clear, as there were no reasons for the increase in drug prices and their reflection in this way on the insurance budget, and there were no global reasons for the increase in prices as well, but the cartels that control prices locally and the structure of drug relations between the monopolist - importer, seller - pharmacist, and consumer - patient guaranteed or any other guarantor, were governed by balances that tend to achieve huge profits funded by the guarantee over long periods. This study is only a fraction of what can be inferred from more in-depth studies of this relationship.
Therefore, this study reveals the danger of continuing an approach that is subject to monopolies.
Facing this requires a quick decision from the Insurance Department first to adopt the study and rely on it to carry out other studies in the field of hospital coverage, for example, or in the field of coverage of medical services outside the hospital (laboratories and others) to reach mechanisms that restore coverage to the insurers, and may allow its expansion later, while at the same time curbing the greed of traders - medical service providers importing drugs, medical supplies, laboratories, pictures or surgical services. Hotel accommodation in hospitals...
All these services, which were covered by the warranty for a large percentage of their cost ranging from 80% to 100%, can be returned according to the rules of new relationships between the warranty and the service providers.
All this study did was redivide the basis for calculating drug coverage into “the least expensive drug in every scientific combination. ”
On the current basis of the guarantee, restoring medical coverage would cost the Sickness and Maternity Insurance Branch $112 million compared to $73 million in adopting the new rule.
The difference is $39 million, or 53% of the estimated cost of the new calculation rule.
That ’ s not counting the subsidy hike, which will increase costs by 34% on all options.
Two-thirds of covered medicines cost less than 100,000 lira
The study indicates that about two-thirds of the Fund ’ s contribution to the medicine bill outside the hospital is due to medicines priced less than 100,000 liras, and that it represents 98% of the amount of medicines contributed by the Fund.
The remaining third is distributed between 8% on medicines whose official price ranges between 100,000 and 300,000 liras, and 29% on medicines whose official price exceeds 300,000 liras.
In the current classification of the medicines in force in the guarantee, i.e. the "Anatomical Therapeutic Chemical System (ATC)", the drugs of the cardiovascular system, digestive system and metabolism accounted for one-third of the medicine budget in the box and 44% of the quantities of drugs consumed, compared to a quarter of the budget of the box and an amount not exceeding 1% for anti-tumor drugs and immune-modifying agents.
Every dollar spent by the guarantee to cover the bills of medicine outside the hospital is distributed as follows:
- 23 cents on anti-tumor drugs and immune-modifying agents
- 17 cents on cardiovascular drugs.
- 17 cents on digestive and metabolic drugs.
- 10 cents on blood medications and hematopoietic organs
- 8 cents on antiseptic drugs for systemic use.
- 7 cents on nervous system meds.
- Six cents on respiratory medication.
- 12 cents on the rest of the medicine.
According to the new classification of drugs proposed by the Technical Committee, namely, according to the categories of “priority of decreasing coverage ”, it was found that the drugs used in acute treatment are among the most requested drugs by 46% of the amount of units of medicine contributed by the Fund, followed by drugs used for chronic diseases by 43%.
- 40 cents on medicines used for chronic diseases
- 24 cents on medications used in acute therapy
- 24 cents on cancer drugs and chemotherapy.
- 12 cents on the rest of the medicine.
22%
It is the share of Generic medicines from the total budget of the medicine in the guarantee, although it accounts for 42% of the amount of medicine paid for by the guarantee, and in contrast, the branded medicines represent about 55% of the amount of medicine and 61% of the budget of medicine
2.4 Beneficiary
The number of beneficiaries is estimated to be about 1.46 million beneficiaries for 2025, noting that the number of insured persons estimated to be 606 thousand.
$112 million
It is the estimated cost to cover the drug bills in the rates currently in force in the guarantee and without any modification in the mechanisms of dealing with the categories of drugs, which is contrary to what the study suggests in terms of dealing with the lowest price per unit of medicine in each drug formulation.
$239 million
It is the value of the contributions that the insurance is supposed to collect from the employees registered with it for the benefit of the sickness and maternity insurance branch in the current year, on the basis of which the average monthly wages were calculated between 30 million lira for the wage earner and 24 million lira for the teacher, 45 million lira for the doctor, 18 million lira for the pensioner and 36 million lira for the optional content.
NEWS
MORE ABOUT
ADVERTISE HERE
JUST IN
TRENDING
HEADLINES
{{headlineCount}} new {{headlineCount = = 1?
'update': 'updates'}}
+ MORE HEADLINES
TRENDING
• online ordering system for restaurants
• The best online ordering systems for restaurants
•

This report highlights real-world examples of how these shortages have impacted ordinary patients and how authorities responded.

Title:

Content: Thursday, 14 Jumada I 1444 Hijri, corresponding to 08 December 2022 AD
A medical crisis in Kuwait.
Urgent parliamentary action
Contact – Editorial Team:
Two deputies in the Kuwaiti National Assembly submitted two requests to the Parliamentary Health Affairs Committee to study the causes of the shortage of medicines, which has become a crisis threatening the health of Kuwaitis, according to media reports.
Medications are not available for dispensing
MP Dr. Jenan Bushehri sent a letter to the National Assembly, in which she confirmed that “despite the assurances of officials in the Ministry of Health of sufficient pharmaceutical stock for the community, many medicines are not available for disposal, which makes the general health situation on the verge of collapse, ” according to“ Al-Qabas ”.
Boushehri asked the Health Affairs Committee to study the causes of the shortage of medicines in private and private health institutions and centers, and to submit its report in the next session, including the causes, results, recommendations and those responsible for the crisis.
The MP stressed that all constitutional options are available in the event of any complacency or inaction in the development of permanent solutions that preserve the health of the population of the State of Kuwait.
Also read:
18 "homosexuals" arrested in a massage and massage center in Kuwait..
They committed adultery and lured teenagers.
200 drugs not available
MP Faisal al-Kandari asked Prime Minister Sheikh Ahmed Nawaf al-Ahmad al-Sabah to form an investigation committee on the lack of medicines and irregularities in the Ministry of Health, and said: "We will wait for the results before using constitutional tools."
Al-Kandari added: “I continue to extend a helping hand to the government for the benefit of Kuwait and its people, and I have gradually used constitutional tools, waiting for the procedures to address the issue of the unavailability of more than 200 types of medicines. ”

---

### Case 1: Lebanon – Drug Shortages Amid Economic Crisis (2022)

#### Affected Medications
- Medications for chronic diseases such as **diabetes**, **heart disease**, **epilepsy**, and **cancer**.

Title:

Content: Thursday, 14 Jumada I 1444 Hijri, corresponding to 08 December 2022 AD
A medical crisis in Kuwait.
Urgent parliamentary action
Contact – Editorial Team:
Two deputies in the Kuwaiti National Assembly submitted two requests to the Parliamentary Health Affairs Committee to study the causes of the shortage of medicines, which has become a crisis threatening the health of Kuwaitis, according to media reports.
Medications are not available for dispensing
MP Dr. Jenan Bushehri sent a letter to the National Assembly, in which she confirmed that “despite the assurances of officials in the Ministry of Health of sufficient pharmaceutical stock for the community, many medicines are not available for disposal, which makes the general health situation on the verge of collapse, ” according to“ Al-Qabas ”.
Boushehri asked the Health Affairs Committee to study the causes of the shortage of medicines in private and private health institutions and centers, and to submit its report in the next session, including the causes, results, recommendations and those responsible for the crisis.
The MP stressed that all constitutional options are available in the event of any complacency or inaction in the development of permanent solutions that preserve the health of the population of the State of Kuwait.
Also read:
18 "homosexuals" arrested in a massage and massage center in Kuwait..
They committed adultery and lured teenagers.
200 drugs not available
MP Faisal al-Kandari asked Prime Minister Sheikh Ahmed Nawaf al-Ahmad al-Sabah to form an investigation committee on the lack of medicines and irregularities in the Ministry of Health, and said: "We will wait for the results before using constitutional tools."
Al-Kandari added: “I continue to extend a helping hand to the government for the benefit of Kuwait and its people, and I have gradually used constitutional tools, waiting for the procedures to address the issue of the unavailability of more than 200 types of medicines. ”

Title:

Content: Continued complaints about the scarcity and rise of medicine in Khartoum
Khartoum: Ali Turkmani
Medicines and medical drugs are one of the basic needs of a healthy citizen ’ s life. Chronic and non-chronic diseases are endemic within the community. The suffering is overcome by the frightening rise in prices to the extent that the community worries and threatens the completion of recovery because the high prices are not commensurate with the limited sources of income of citizens.
Where many are unable to buy their important medicines; because of the high prices, and others and large proportions have been buying less than the required amount according to his financial ability,
Employees of large companies and institutions provide them with medical insurance in the best hospitals in the capital and are the most able to buy their pharmaceutical supplies by paying a small percentage of the total value of the drug.
The citizen Mohannad Al-Fateh told Al-Sudani that one of the worst increases caused by black markets, and the citizen Sadiq Hassan complained about the rise of medicines recently with the economic deterioration in all aspects of life, which puts pressure on the citizen and can not provide treatment to increase the prices of medicines in a way that aggravates the suffering of the poor citizen.
Pharmacist Mirghani Habibullah, director of Al-Reda Pharmacy in Khartoum, told Al-Sudani that the increase in the dollar has greatly affected the prices of medicines.
He added that local companies that manufacture the drug increased their prices by 30%.
Habibullah pointed out that the companies that import from abroad increased from (10% to 20%), and stressed that the increases in all prices of medicines, in addition to life-saving medicines, and estimated the availability of medicines in the market by (80%).
He added that the lack of availability of some medicines is due to the fact that they are not registered for import.
Habibullah continued that the most expensive drugs are diabetes, pressure and crisis medicine.
He pointed out that the increases made citizens buy their medicines retail according to their ability and economic conditions.
He added that there is limited stability in the prices of medicines, while the pharmacist (P.A.), who preferred to withhold his name, said that the drug market became free if the dollar increased (10%), the drug increases by the same value, and that sometimes increases in prices are due to fuel and electricity as well.

Title:

Content: There are problems, but there will be no shortage: pharmacies explained why there are not always the necessary drugs on sale
The ongoing war, unjustified growth in demand and problems with production lead to a short-term absence of certain drugs in pharmacies.
Martial law imposes additional difficulties on the import of medicines, but Ukrainian pharmaceutical companies have practically solved this problem: they produce 61% of medicines from the National List of Medicines.
About this Delo.ua told pharmacists and manufacturers.
In the pharmacy holding ANC explain that they fix several main reasons why some positions may disappear in the network:
1.
Due to the martial law in the country, the supply of goods from abroad is irregular, because not every carrier is ready to transport the goods to a country where hostilities continue;
2.
In such cases, insurance companies do not cover the transportation of goods due to high risks;
3.
Completion of the registration period of the goods;
4.
The company producing the goods decided to leave the Ukrainian market.
While data on foreign trade are available only in the context of 4 digits of the code UKTVED, more detailed statistics are not published in the conditions of martial law.
But these data also indicate a reduction in the supply of drugs from abroad, which was confirmed in Goslikluzhba.
Pharmacists note that they do not affect suppliers or the supply of goods.
If the drug is absent from the main distributors, the pharmacist can only recommend analogues to the client in the positions that he can offer.
“At the same time, unfortunately, there is no alternative for unique imported drugs.
Probably, if the state provided manufacturers and suppliers with additional guarantees, this could change the situation, ” adds Maria Semenova.
At the same time, as noted in the pharmaceutical company "Darnitsa", with temporary problems with the presence of a foreign medicine, Ukrainian manufacturers can offer generics of similar quality.
Pharmacists agree that manufacturers are successfully closing the gap in the market, but note that they do not produce innovative new drugs of the latest generations and original drugs, as well as drugs necessary for the treatment of rare diseases.
At the same time, the reduction of imports of medicines to Ukraine has a positive effect - it contributes to the growth of the production of domestic medicines.
Because, as noted in "Darnitsa", an increase in the production of domestic drugs leads to GDP growth, the number of jobs and tax revenues to the country's budget.

Title:

Content: Wednesday 18 Jumada II 1444 AH - 11 January 2023 |
Programs
Watch our latest episodes online
A disaster in pharmacies.
Our children are in danger!
With a single word or a single word: “cut. ”
Often, this is the answer in pharmacies when you ask about a medicine or a bottle of milk for your child.
It is as if the country had emptied all the medicines at the same time, even as if it were a death sentence for those who decided to stay in Lebanon.
It is the most heinous form of torture experienced by our people today, which is not enough that it is plundered, stolen and condemned by the most failed and despicable politicians, but it is also deprived of medicine.
Different types of drugs are cut off, even those for chronic diseases that patients cannot miss taking at the specified time...
The search for a drug became more like a sinister journey from the north to the Bekaa in the south, and in vain tried to...
Worse, than mentioned above, is the interruption of antibiotic medicines for children, of which it is impossible to find a single package in all of Lebanon, and if you do, the date of its validity will be outdated, which is forcing parents to replace them with less effective drugs with larger calibers.
The Chief Pharmacist Joe Salloum explains the issue for one of two reasons. The first is that some medicines are still partially subsidized (between 20 and 30 percent), so the delay is caused by the absence of support funds and the delay in obtaining the prior approval to open a credit in the bank, which delays the import process.
The second reason is the problem that arose between companies importing medicines at home and those exporting abroad due to delays in the payment of bills, which made Lebanon last on the list of countries that give priority to obtaining medicines, and became the preference for others who commit to pay on time.
“A great disaster, ” Salloum describes the scene today in the pharmaceutical and hospital sector in Lebanon, calling for a comprehensive solution starting with the election of a president of the republic and the formation of a new government to develop an integrated plan for the problem of importing medicine.
Probably, as bad as we've experienced, we'll be waiting a long time for the president, the new government, and, of course, the comprehensive drug plan.
And in this lost time, one piece of advice for those who hold the helm of this crumbling country...
Beware of the anger of mothers who carry their child who groans from heat and disease and do not find a medicine to alleviate his pain...
Beware of their anger, which will be darker than your biggest nightmares.

Title:

Content: Israel faced an acute shortage of various drugs: the Association of pharmacists announced the details
Pharmacists said that the problem is not properly solved by state bodies, in particular the Ministry of Health.
The Association of Pharmacists has warned of an acute shortage of drugs, including Ritalin, drugs used to treat heart and blood vessel problems, and drugs to treat skin diseases.
Pharmacists wrote about it in a letter sent to Health Minister Nietzan Horowitz and his office ’ s CEO, Nachman Ashe, on Monday.
There is a shortage of medicines in Israel.
In the past two years, and in particular in the last few months, the phenomenon of shortages has intensified, ” said David Pepo, chairman of the Association of Pharmacists.
“The shortage is understandable for a number of reasons: COVID-19, the war in Ukraine, the global employment crisis and the economic crisis, ” Pepo explained.
“To this should be added the serious disruptions taking place in the distribution systems of medicines in Israel, which are due to staff shortages, malfunctions, high distribution costs and many other explanations of all sorts, ” Pepo said.
Earlier, Cursor wrote that in supermarkets in the coming days, a shortage of chicken and turkey is expected.
Recall that scientists have named a substance that reduces the risk of suicide.
In addition, the Minister of culture Healy Tropper said whether to cooperate with Netanyahu.
Read the latest news from Israel and the world on the Kursor channel in Telegram.
Author of the material:
TAGS:

Title:

Content: Lack of medicines in the Gaza Strip increases the suffering of Palestinians
The Palestinian Ministry of Health warned this week of a “shortage of medicines and medical consumables and a shortage of primary care items amounting to more than 60% of the basic list of primary care medicines. ”
An empty pharmacy in the Gaza Strip (Getty)
In Rafah pharmacies in the southern Gaza Strip, Mohammed Khader is searching for medicines for his father and sister, but he is facing extreme difficulty in finding them amid a severe shortage in the Strip due to the Israeli aggression for months, for which Israel is being tried before the International Court of Justice on charges of genocide, which has so far claimed the lives of some 30,000 martyrs, mostly children and women.
“This is the fifth pharmacy I am looking at, ” says the young man who fled to Rafah from Jabalia in the northern Gaza Strip, explaining,“ I found only one of three types (medicines) prescribed by the doctor, my father has a hole in the eardrum due to the shelling and he suffers all the time. ”
“My sister has chronic SLE and she needs four types of treatment, only one of which is available.
“Her health is deteriorating very badly, she is in great pain and we can ’ t do anything. ”
This week, the Palestinian Ministry of Health warned of a “shortage of medicines and medical consumables and a shortage of primary care items amounting to more than 60% of the basic list of primary care medicines. ”
The ministry said there were 350,000 people with chronic diseases without medication and warned of "serious health complications for patients".
In his pharmacy in Rafah, pharmacist Mohammed Sehwail says that what is happening is a “catastrophic period, ” explaining that“ not all types of drugs are available, especially for chronic diseases such as heart disease, stress, diabetes and cancer. ”
There is a shortage of children ’ s medicines, antibiotics and even painkillers. ”
"Even alternative medicines that may help in some cases have run out for months."
In another pharmacy, pharmacist Abdulhadi Dheer apologizes to a man who asks him about several types of medicines for Parkinson ’ s disease, while a woman leaves frustrated that no medicine has been found.
"The need for medicine has reached its peak, especially with the spread of diseases and epidemics due to overcrowding, malnutrition and living conditions," he said.
He points out that many come and “suffer from the symptoms of hepatitis, which is serious, but we feel helpless, there are no drugs, we cannot intervene without the guidance of doctors, even the alternatives to drugs have run out. ”
Some 1.4 million Palestinians, more than half of Gaza ’ s population, are crammed into Rafah amid desperate humanitarian and living conditions and a high risk of disease, according to the United Nations.
The Gaza Strip has been under an Israeli blockade since 2007, and this blockade has been tightened since the beginning of the Israeli aggression on the Gaza Strip, which receives little aid.
The Palestinian Ministry of Health warned that the accumulation of displaced people in the cold "has increased the spread of respiratory, skin and other infectious diseases," including hepatitis A.
In October, Israel launched a concentrated bombing campaign, followed by a massive ground offensive in the Strip, killing 28,663 people in the Gaza Strip, the majority of them women and children, according to the Palestinian Ministry of Health.
In the west of Rafah, more than 200 people stand in line in front of the pharmacy of the Kuwaiti hospital, waiting for their turn, carrying prescriptions and hoping to obtain the required medicines.
Jihan al-Quqa, displaced from Khan Younis, who has come since early morning, complains: “We stand for hours to get a pill.
They give us a pill. There are no antibiotics, no treatments.
The children are sick and the elderly. ”
“My husband has diabetes and his leg is swollen but we can ’ t get medicine for him.
Doctors say he has clogged veins because he doesn ’ t take medication. ”
Abdallah al-Haj, who had his leg amputated, sits in a wheelchair and laments, “There is no pharmacy in Rafah that has pain relief for me to sleep at night. ”
Months after the war broke out in October, Gaza ’ s health system appears to have collapsed.
According to the UN, there are no fully operational hospitals in Gaza, and only 13 of the 36 medical facilities across the Strip are operating at limited capacity.
On Wednesday, the health agency warned that hospitals in Gaza lacked “adequate supplies. ”
Doctors are forced to perform amputations due to a lack of means to treat patients and save their limbs, according to the World Health Organization ’ s local representative, Dr. Rick Peppercorn, from Gaza.
Nabil al-Othmani, 60, comes every day to ask about the medication he needs for epilepsy, but to no avail.
Trying to hold back his tears, he explains, “they tell me he ’ s not available at all. ”
Mohammad Yaghi, displaced from Gaza City, said: “We are slowly dying.
Because of the lack of medicines and treatments inside the city of Rafah. ”

Title:

Content: PRIMPRESS.RU
38 followers
The head of the Ministry of health said about the sufficient number of medicines
The head of the Ministry of health of the Russian Federation Mikhail Murashko said that the demand for drugs has increased tenfold, but for beneficiaries there is a stock of necessary medicines for almost six months, reports PRIMPRESS.
Back to article
Picture of the day
top

Title:

Content: In Israeli pharmacies shortage of drugs: details
The shortage is due to logistics problems and increased demand.
In health insurance funds and private pharmacies, there is an acute shortage of cold medicines, the demand for which is growing in the winter.
This is reported by Mako.
In many pharmacies, it is impossible to find individual types of "Akamol" (paracetamol).
There was a shortage of medicines for colds, coughs, sore throats.
The shortage is due, among other things, to logistics problems and increased demand.
Pharmacists Association Chairman David Pepo spoke to the deputy director of the Department of Pharmacy at the Ministry of Health last week, and nothing has been done since, he said.
Earlier we told that soon in Israel will launch a pilot project on the operation of autonomous buses, which will result in the country will appear commercial bus routes with cars without drivers.
Now announced four groups of companies that have won the competition of the Ministry of Transport for the implementation of the pilot project.
The cost of the pilot project is 61 million shekels, half of which is provided by the state.
It was organized jointly by the Ministry of Transport, the Public Transport Authority, the Innovation Authority and Netivei Ayalon.
Find out more here.
Cursor also reported that the number of tourists in Israel has been growing since the beginning of the year.
So, since January 2022, 2.2 million tourists have visited the country.
There was also an increase in the number of Israelis who left the country as tourists.
In addition, the Ministry of Health took measures in connection with concerns about the shortage of epidural anesthesia kits.
Read the latest news from Israel and the world on the Kursor channel in Telegram.
Author of the material:
TAGS:

Title:

Content: VK Press
55 followers
They want to make Russia suffer and deprive vital medicines: the pharmacist went crazy
According to him, Moscow cannot sell medicines because they allegedly go for the needs of the military.
He also recalled that the economic war against Russia is being waged with the aim of strangling it and social isolation.
Back to article
Picture of the day
top

Title:

Content: svoyblog
4 followers
The Ministry of Industry and Trade announced the risk of a shortage of vital drugs
The Ministry of Industry and Trade of Russia receives information from the regions about the lack of immunoglobulin preparation.
This was told in the department.
Back to article
Picture of the day
top

Title:

Content: 16 November, Tuesday
Ekaterinburg
Ekaterinburg
Log in
Buy advertising
WE ARE ON SOCIAL NETWORKS
SUBSCRIBE TO OUR NEWSLETTERS
Sign up
In Russia, there is a catastrophic shortage of medicines.
The whole thing is in the course of the country on import substitution Children 's oncologist Alexander Karachunsky tells about the problem
In Russia, there is a catastrophic shortage of medicines.
It 's all about the country' s import substitution
About the problem tells children 's oncologist Alexander Karachunsky

Title:

Content: Locally
2022-08-02 04: 30: 55
Daily News
The shortage of commonly used pharmaceutical factories has led to the unusual practice of the Mainland and Western Medicine Hospital Authority
Share:
Hospital Authority Director of Cluster Services, Mr Tang Yiu-keng (pictured), pointed out that because of the shortage of paracetamol, the Hospital Authority purchased paracetamol tablets from the Mainland. He pointed out that when the situation is urgent, it is very unusual to use the designated patient drug use plan to introduce drugs. Production to avoid common drug shortages.
As for the earlier switch to the mainland antibiotic "cefoxidine for injection", which was also supplied by the original drug manufacturers, the mainland version was imported to cope with the sudden surge in demand.
The supply situation is stable and the use of the same antibiotics as the original contract has been restored.
Chief Pharmacist of HA, Mr Lee Shing-cheung (first from left), said that the percentage of pharmaceutical products purchased by HA in China remained stable at about 3%, with no significant increase.
Mr Tang reiterated that the Bureau will adhere to four major principles when purchasing drugs, including whether the drugs are registered and GMP regulated by the Department of Health; ensure product specifications by means of medicines; pass non-proprietary drug interchangeability tests and demonstrate bioequivalence to the World Health Organization (WHO) requirements; and give priority to the use of drugs with English drug names on the label.
Privacy Protection Policy
Please read and accept the following privacy policy and disclaimer carefully. By clicking "Accept", you agree to and agree to the privacy policy and disclaimer contained in the am730 website.
LEARN MORE
Acceptance

Title:

Content: Tuesday 18-04-2023
Health of MPs: Severe shortage of medicines in government hospitals
The head of the Parliamentary Health and Environment Committee, Dr. Firas Al-Qudah, said that there is a severe shortage of medicines in government hospitals.
Add Announcement
This came during his chairmanship of a committee meeting held on Tuesday, in which they discussed the procedures followed to transfer doctors in the Ministry of Health, the reality of health centers in the Kingdom, as well as the development and modernization of services provided by the Ministry.
The meeting was attended by the Minister of Health, Dr. Firas Al-Hawari, the Secretaries-General of the Ministry for Epidemiology and Communicable Diseases, Raed Al-Shboul, and the Technical and Administrative Affairs, Mr. Khreisat, and a number of transferred doctors.
For their part, the deputies: Farid Haddad, Tayseer Krishan, Ayman Medanat, Ali Tarawneh, Suleiman Abu Yahya, Omar al-Nabr, Mohammed al-Shatnawi, Hadiya al-Sarhan, Mohammed al-Khalayla, Ahmed al-Sarahneh, Hayel Ayash, Abdullah Abu Zaid, Talal al-Nsour, demanded the release of the list of doctors' wages.
They stressed the importance of solving the problem of shortage of medicines in government hospitals and health centers, calling for the construction of hospitals in various provinces to alleviate the pressure on citizens.
They noted the importance of promoting medical tourism in the Kingdom.
Al-Hawari said that Aqaba Hospital will be transformed into a children ’ s and dialysis hospital, denying the existence of any Gulf grant to develop the hospital.
He added that there is an agreement signed between the ministry and the Royal Medical Services to conduct catheterization operations at the Karak government hospital.
Al-Hawari explained that there is a trend to modernize Ajloun Hospital to provide its services to the northern region, as well as the construction of a hospital in Irbid with a capacity of 550 beds, and it is possible to reach a capacity of 650 beds.
He added that this hospital will be specialized in catheterization, tumors and other diseases, stressing that the construction of the hospital does not mean at all the closure of the King Abdullah University Hospital.
Al-Hawari pointed out that the structure of the ministry has achieved a saving of two million and 260 thousand dinars, pointing to the positive impact on the services provided by the ministry to citizens.
He denied the talk about the bankruptcy of the health insurance fund, stressing at the same time that the ministry has nothing to do with the list of doctors' wages, but the concerned doctors' union.
Al-Hawari stressed that the services provided by the health sector in the Kingdom are stronger and better before, during and after the coronavirus pandemic.
He said that the decision to transfer doctors from sports centers in the sports city to al-Bashir hospital is a sound decision that fights sagging and will not be reversed.
On the shortage of medicines in hospitals, Al-Hawari said there was a delay in the settlement with the warehouses and pharmaceutical companies, noting that in the absence of medicines in hospitals or centers, the prescription is stamped to be dispensed from private pharmacies based on health insurance.
Al-Hawari pointed out that three conferences have been held to encourage medical tourism in the Kingdom.
He added that there is an existing service through a smart phone application to deliver medicines to sick citizens for 2 dinars.

Title:

Content: The Most Fashionable
243 followers
Missing from pharmacies vital medicine will arrive the next day
The Minister of Health of Karelia announced when and where it will be possible to buy Eutirox The head of the Ministry of Health of Karelia publicly responded to appeals about the shortage of the vital drug Eutirox.
Back to article
Picture of the day
top

Title:

Content: Right now
-1 ˚ C
Now in St. Petersburg
-1 ˚ C
Cloudy, little snow
It feels like -3.
1 m / s, south
758mm
88%
Read more
Traffic jams
3 / 10
December 20 - round table "Leaders on the main thing: what happened in medicine in 2022"
1386
Not yet having time to go from the coronavirus, the medical industry has faced the consequences of sanctions.
Despite the fact that most companies promised not to affect medicine, logistics became more complicated, prices for drugs and equipment) grew along with the exchange rate of foreign currencies (and then did not fall back so quickly).
What was the year 2022 for medicine in general and for individual clinics — in particular, we will discuss at a round table.
Questions for discussion:
- What influenced the medical industry in 2022: covid, sanctions, other factors?
- What challenges did medicine face and how did it address them?
- Demand for private medicine in 2022: what influenced it?
In which segments was the growth?
- The main achievements of medical companies in 2022 - what contributed to the success?
Did medical services go up in 2022?
Where is the growth stronger?
- Has the medical sector received any support from the state?
Is it needed and in what form?
- New and old players - how will the market of medical services develop?
Heads and doctors of medical institutions are invited to participate
According to the results of the round table, a publication is planned on the Doctor Peter website with an announcement on Fontanke.ru.
For participation, please contact:
Irina Egorova, tel.
8 – 951 – 640 – 88 – 72, egorova @ fontanka.ru
Plan of activities
LIKE0
LAUGHT0
SURPRISION0
RAGE0
FURNITURE0
JOIN NOW
The brightest photos and videos of the day - in our groups in social networks
Did you see the typo?
Select a fragment and press Ctrl + Enter
report news
Send your news to the editor, tell about the problem or throw a topic for publication.
Upload your video and photo here.

Title:

Content: December 15, 2022
15 December 2022 ° C
50 medicines missing in Algeria, rare reasons
+ - 0 Read
President of the National Union of Private Pharmacists, Massoud Belambri, revealed that about 50 pharmaceutical brands are missing in Algeria, expressing regret that the regulation of the pharmaceutical market in Algeria has not been reached, despite efforts, legal reforms, inspection, control and reporting.
He explained that the scarcity of medicines is due to internal and external reasons, as the international market recorded a scarcity of medicines, such as paracetamol and amoxicillin, due to the scarcity of raw materials (which are included in medicines) and their high prices, and the countries producing raw materials give priority to their local market.
At the national level, the same speaker explained that the scarcity of medicines is linked to some legal texts that are not in line with the market, and the behavior of some drug distributors who "have turned into large wholesalers and suppliers of other distributors, and this behavior caused a great disruption in the distribution of medicines.
The radio guest called on the concerned authorities to take measures to avoid aggravating the situation.
By reviewing the prices of some drugs to ensure their availability and continued manufacture on the market.
He stressed that there is a fluctuation in the availability of insulin (despite the import of quantities of it, but the suffering has continued for more than a year.
On the other hand, the President of the Syndicate was surprised by the withdrawal of medicines from the national market and despite the publication of this list, doctors still prescribe them in the prescriptions, and here it must be pointed out the importance of coordination, communication and updating information.
Share your opinion

Title:

Content: Gazeta.ru on desktop
for quick access
Install
Not now
Financial Times: The European Union has decided to create a strategic supply of scarce drugs
The European Union (EU) intends to create a strategic supply of medicines and oblige manufacturers to guarantee their supply.
This is reported by the Financial Times with reference to the representative of the European Commission (EC).
According to the interlocutor of the publication, the shortage of pharmaceuticals is a “systemic challenge ” for EU member states, so the EC intends to ensure“ strategic autonomy ” in the supply of essential drugs, such as paracetamol and penicillin.
The FT source also said that in the near future the European Commission will introduce a law that will allow “to ensure access of all patients in need to medicines. ”
For this purpose, it is planned to “introduce stricter obligations for suppliers, improve the availability of information on drug stocks, and require earlier notification of shortages. ”
According to the European Commissioner for Health Stella Kyriakidis, discussion of these measures with representatives of the industry has already taken place.
Earlier it was reported that the French authorities banned the online sale of paracetamol until the end of January 2023 due to problems with the supply of the drug.
According to a press release from the French government, the tense situation with the supply of drugs based on paracetamol persists in France for more than six months.
This also applies to drugs intended for children.
Share:
Downloading
Found a bug?
Close

Title:

Content: HI, {{username}}
Manage account
Change password
HEADLINES
{{headlineCount}} new {{headlineCount = = 1?
'update': 'updates'}}
+ MORE HEADLINES
Health Minister: Most of the problems we see are due to lack of funds
21.
MAY
2022
A
+
A
- Ah!
Print
Email
Email
A
+
A
- Ah!
Minister of Public Health Firas Al-Abyad said that "no one can afford the drugs for cancer and incurable diseases, and the Council of Ministers will support the item related to the support of the drug for four consecutive months."
He pointed out that "the crisis we are going through is unprecedented, as well as other factors such as administrative disruption and quarrels," adding: "Our problem is outside the scope of the ministry and we ask everyone to intensify efforts."
He said: “Most of the problems we ’ re seeing are the result of a lack of money.
We are going through exceptional circumstances and everyone should join hands to get the country out of the impasse. ”
MORE ABOUT
ADVERTISE HERE
JUST IN
TRENDING
HEADLINES
{{headlineCount}} new {{headlineCount = = 1?
'update': 'updates'}}
+ MORE HEADLINES
TRENDING

- Essential drugs used in **intensive care units** (ICUs) in hospitals.

#### Reasons Behind the Shortages
1.

Title:

Content: Thursday, 14 Jumada I 1444 Hijri, corresponding to 08 December 2022 AD
A medical crisis in Kuwait.
Urgent parliamentary action
Contact – Editorial Team:
Two deputies in the Kuwaiti National Assembly submitted two requests to the Parliamentary Health Affairs Committee to study the causes of the shortage of medicines, which has become a crisis threatening the health of Kuwaitis, according to media reports.
Medications are not available for dispensing
MP Dr. Jenan Bushehri sent a letter to the National Assembly, in which she confirmed that “despite the assurances of officials in the Ministry of Health of sufficient pharmaceutical stock for the community, many medicines are not available for disposal, which makes the general health situation on the verge of collapse, ” according to“ Al-Qabas ”.
Boushehri asked the Health Affairs Committee to study the causes of the shortage of medicines in private and private health institutions and centers, and to submit its report in the next session, including the causes, results, recommendations and those responsible for the crisis.
The MP stressed that all constitutional options are available in the event of any complacency or inaction in the development of permanent solutions that preserve the health of the population of the State of Kuwait.
Also read:
18 "homosexuals" arrested in a massage and massage center in Kuwait..
They committed adultery and lured teenagers.
200 drugs not available
MP Faisal al-Kandari asked Prime Minister Sheikh Ahmed Nawaf al-Ahmad al-Sabah to form an investigation committee on the lack of medicines and irregularities in the Ministry of Health, and said: "We will wait for the results before using constitutional tools."
Al-Kandari added: “I continue to extend a helping hand to the government for the benefit of Kuwait and its people, and I have gradually used constitutional tools, waiting for the procedures to address the issue of the unavailability of more than 200 types of medicines. ”

Title:

Content: The site uses cookies and analytics systems to personalize services and convenience.
By continuing to browse, you authorize their use
Find arbitrary text:
1.
Brand selection
2.
Model selection
How to choose
Car prices will rise: the shortage of automotive components reached a record level
The shortage of materials and spare parts in the global automotive industry has once again increased.
This follows from a survey conducted this week in Germany by the Ifo Institute.
Photo by Volkswagen
On the problems with the procurement of raw materials in December 2021, 93% of car companies complained.
In November, the figure was 74%.
This is paradoxical, Klaus Milrabe, head of the Ifo Institute, said on Thursday: “The order books are full, but the shortage of materials does not allow enterprises to increase production accordingly. ”
Manufacturers of electrical equipment suffer the most, with a share of 94%, followed by the automotive industry with a figure of 93% and mechanical engineering (91%).
Alas, the current situation inevitably leads to an increase in prices for final products, including cars.
“At least one in two companies surveyed plans to raise their prices in the next three months, ” said Mr. Millabe.
Subscribe to our channel in Google News and Yandex.Zen: more interesting news every day.
Found an error or inaccuracy?
Press CTRL and ENTER and tell us about it
Yandex.News
REMEMBER
Transport tax
Region
Vehicle type
Power
bhp
Period
mr.

Title:

Content: In Israeli pharmacies shortage of drugs: details
The shortage is due to logistics problems and increased demand.
In health insurance funds and private pharmacies, there is an acute shortage of cold medicines, the demand for which is growing in the winter.
This is reported by Mako.
In many pharmacies, it is impossible to find individual types of "Akamol" (paracetamol).
There was a shortage of medicines for colds, coughs, sore throats.
The shortage is due, among other things, to logistics problems and increased demand.
Pharmacists Association Chairman David Pepo spoke to the deputy director of the Department of Pharmacy at the Ministry of Health last week, and nothing has been done since, he said.
Earlier we told that soon in Israel will launch a pilot project on the operation of autonomous buses, which will result in the country will appear commercial bus routes with cars without drivers.
Now announced four groups of companies that have won the competition of the Ministry of Transport for the implementation of the pilot project.
The cost of the pilot project is 61 million shekels, half of which is provided by the state.
It was organized jointly by the Ministry of Transport, the Public Transport Authority, the Innovation Authority and Netivei Ayalon.
Find out more here.
Cursor also reported that the number of tourists in Israel has been growing since the beginning of the year.
So, since January 2022, 2.2 million tourists have visited the country.
There was also an increase in the number of Israelis who left the country as tourists.
In addition, the Ministry of Health took measures in connection with concerns about the shortage of epidural anesthesia kits.
Read the latest news from Israel and the world on the Kursor channel in Telegram.
Author of the material:
TAGS:

Title:

Content: Now in short supply not only chips, but also passive components
An acute shortage of chips has plagued many consumer electronics manufacturers since the spring of 2020.
Back to article
Picture of the day
top

Title:

Content: 2 major drugs are in short supply, FDA says. Both are widely prescribed to children.

NEW!

Drug shortages continue in the U.S., even as the COVID-19 pandemic nears the end of its third year.

Two drugs commonly prescribed to children — Adderall and liquid amoxicillin — recently joined the list, the Food and Drug Administration says.

The FDA announced last month that it was talking to manufacturers about a shortage of Adderall, the combination drug of amphetamine mixed salts used to treat attention deficit hyperactivity disorder.

Parents are also discovering liquid amoxicillin — an important antibiotic used to treat bacterial infections — is in short supply, according to the FDA. It added the oral solution of the antibiotic to its list of drug shortages on Oct. 28.

Both drugs are widely used by children as well as adults. The amoxicillin shortage comes at a vulnerable time, as we enter cold and flu season and U.S. hospitals continue to fill with respiratory infections. Amoxicillin is often used to treat ear infections and bronchitis.

The reason for the shortages? The FDA didn’t immediately respond to a request for comment Thursday. However, the agency cited a few factors on its website, including quality and manufacturing issues.

“There have been other reasons such as production delays at the manufacturer and delays companies have experienced receiving raw materials and components from suppliers,” the agency says. “Discontinuations are another factor contributing to shortages.

“FDA can’t require a firm to keep making a drug it wants to discontinue. Sometimes these older drugs are discontinued by companies in favor of newer, more profitable drugs.”

For a list of all drugs currently in short supply, visit FDA.gov.

Our journalism needs your support. Please subscribe today to NJ.com.

Spencer Kent may be reached at skent@njadvancemedia.com.

If you purchase a product or register for an account through one of the links on our site, we may receive compensation.

**Economic Collapse**: Lebanon's severe economic crisis led to a devalued currency, making it difficult to import medications priced in U.

Title:

Content: Drastic cutbacks in the supply of prescription opioids, tougher monitoring of where those pills go and other efforts to curb abuse have had an unintended consequence, Long Island doctors and pharmacists say: People who have a legitimate need for the medicine to relieve severe pain now often have a hard time finding it.

Patients say the shortage means they must endure more pain after they run out of medication. Physicians' staffs sometimes have to call pharmacy after pharmacy to fill patients' prescriptions.

“I have a dozen messages every day from people saying their pharmacy doesn’t have” opioids, said Dr. Edward Rubin, a pain management specialist with offices in Garden City and Lake Success, who said he is careful to prescribe opioids only to patients without good alternatives, particularly those recovering from major surgery.

The opioid medicine shortage that doctors and pharmacists say has emerged over the past few years comes after decades during which pain pills like OxyContin flooded the market and addicted countless Americans. Prescription-drug overdose deaths spiked in the late 1990s and early 2000s.

WHAT TO KNOW

  • Doctors and pharmacists said efforts to reduce the supply of legal opioids to prevent diversion and abuse have gone too far and made it difficult for those with legitimate pain needs to access their medicine.
  • The Drug Enforcement Administration has drastically reduced its annual caps on opioid manufacturing, leading to shortages at pharmacies, which receive a limited number of opioids each month, doctors and pharmacists say.
  • Doctors say opioids were overprescribed in the past, and they are cautious in deciding whether to authorize them for patients. But they said opioids remain the best alternative for some people with severe pain.

Although fentanyl, much of it illegally manufactured, now kills a far greater percentage of people, the number of prescription-drug overdose fatalities in 2021 — 16,706 — is only slightly below the 2017 peak and five times more than in 1999, according to Centers for Disease Control and Prevention data. On Long Island in 2022, more than 700 people died of overdoses of legal and illegal opioids, most of them from fentanyl, Nassau and Suffolk officials said this week.

Rubin and other doctors and pharmacists put principal blame for the opioid shortage on the Drug Enforcement Administration’s declining cap on the amount of opioids pharmaceutical manufacturers can produce each year. For example, the DEA slashed the quota for the most widely produced opioid, oxycodone, which includes the brand names OxyContin and Percocet, from 164 million grams in 2013 to about 54 million in 2023.

“Continuing to throttle the legitimate supply is only hurting legitimate patients at the moment,” Rubin said.

Patients who can’t find their prescribed medicine "are scrambling and switching medications, and we’re adding more risk … [because] I don't know how they're going to respond to a totally different medication," he said.

Tom D’Angelo, owner of pharmacies in Franklin Square, Garden City and Point Lookout and former president of the Pharmacists Society of the State of New York, said the DEA should increase quotas so patients with legitimate pain needs can obtain relief.

He fears that some people in severe pain may resort to buying pills on the street, where something sold as oxycodone may actually be a potentially fatal dose of fentanyl.

“If you’re in enough pain, you’ll try anything,” he said.

Rationing pain-relief pills

John Douglas, 66, of Lake Grove, has been taking opioid medications for several years, first for neck pain, and now also for joint pain from prostate cancer drugs.

“I’m in pain constantly,” he said.

He’s tried several alternatives to opioids and, although the hydrocodone he takes “doesn’t give me 100% relief,” it reduces pain and allows him to work as a physical therapist assistant.

Yet, multiple times, he’s faced delays or uncertainty in obtaining medication, and he’s had to cut pills in half to ration them, which increases his pain.

“I’m sick and tired of every time you go to the drugstore, you don’t know if your medicine is going to be there or not,” he said. “It’s just not right.”

People with legitimate pain are being “penalized” for those who abuse opioids, he said.

Patients nationwide have struggled to obtain their opioid medications. Hundreds of chronic pain patients, medical professionals and others submitted remarks to the DEA last year about the agency's 2023 quotas, some expressing concern that decreases “have resulted in a shortage of opioid medications, interfered with the treatment of patients, and impacted the quality of life for patients possibly leading to suicide,” according to a DEA summary of comments released in December.

Critics, in comments submitted to the DEA and in statements from pharmaceutical executives and others, said DEA quotas on ingredients for attention deficit/hyperactivity disorder medications also are among the reasons for a nationwide shortage of those drugs.

But faced with an ongoing opioid crisis, the DEA has been under pressure to reduce quotas. A 2020 letter to the DEA from Senate Judiciary Committee Chairman Dick Durbin (D-Ill.) and Sen. John Kennedy (R-La.) said despite huge previous cuts in quotas, they were still “excessively high.” Spokespeople for Durbin and Kennedy did not respond to requests for comment.

The DEA in the December report said its quotas are set “in a manner to provide for all legitimate medical purposes.” It also said the limits "help prevent the misuse and diversion of pharmaceutical controlled substances,” and overdoses. A DEA spokeswoman declined to comment further.

The DEA acknowledged in the report that fewer than 1% of five common opioid medications were diverted for illicit uses. Numerous comments also pointed out that despite the drop in quotas, overdose deaths were up — especially from fentanyl and pain pills manufactured illegally outside the quotas.

Mary Silberstein, senior director of strategic alliances and special projects for Hicksville-based CN Guidance and Counseling Services, said restrictions on opioid supply and distribution were “much needed” and have saved lives.

“When you had so many people giving out the prescriptions in such large quantities, you had to have restrictions,” she said.

Silberstein said even though most people with opioid problems currently coming to CN Guidance are misusing fentanyl, a significant number are addicted to prescription opioids.

Opioid prescription rates drop on Long Island

The massive decrease in opioid quotas came after dramatic increases in the 1990s and 2000s. The quota for oxycodone, for example, rose from 3.5 million in 1993, before FDA approval of one of the most widely abused opioids, OxyContin, to its peak of 164 million in 2013. Other opioids had less extreme increases or were taken off the market.

Although the number of opioid prescriptions began falling after 2010, there still were about three times as many opioids prescribed in 2015 as in 1999, when calculated by “morphine milligram equivalents,” to account for differences in drug type and strength, according to a 2017 article in the CDC’s Morbidity and Mortality Weekly.

On Long Island, the number of opioid prescriptions per 100 people fell by more than half in Suffolk between 2012 and 2020, from 66.4 to 29.9, while Nassau’s rate decreased from 49.2 to 41.3, below the national rate of 43.3, according to the CDC. The rate includes people with multiple prescriptions in a year.

Experts say rates are declining in part because doctors turn to opioids more sparingly and there are more controls to flag physicians who prescribe unusually large amounts of opioids. In the past, people abusing opioids “would doctor-shop,” said Dr. Paul Pipia, president of the Medical Society of the State of New York and deputy medical director of Nassau University Medical Center in East Meadow. “There was no way to know who went where.”

There now is an electronic registry of patients’ controlled-substance histories that the state requires medical professionals to review before writing prescriptions. A law capping initial opioid prescriptions for acute pain at seven days, with refills only after further evaluation, limits overprescribing, Pipia said.

Pharmacists say ceilings on how many opioids they dispense each month mean that even though the number of opioid prescriptions is declining, they can't always fill them.

As part of a $21 billion settlement for their alleged role in the opioid crisis, the nation’s three largest pharmaceutical distributors agreed to increase their scrutiny of opioids and limit the quantity they send each pharmacy.

D’Angelo said if he runs out of his monthly opioid allotment, he has to make hard decisions on who gets their medications.

Mukash Patel, owner of pharmacies in Dix Hills and Patchogue, said he sometimes can’t get certain opioids “for days on end.”

“The patient should not have to run around calling 30 different places to see if the drug is in stock,” he said.

Often, pharmacies won’t tell patients if they have a medicine, so Rubin said his staff must make the calls.

“We don't have the bandwidth to be calling a dozen pharmacies for everybody who can’t get their medication,” he said.

Lauren Esposito, spokesperson for one of the distributors in the opioid settlement, Pennsylvania-based Amerisource Bergen, said in a statement that distributors “have been asked to walk a legal and ethical tightrope by both maintaining access to products while simultaneously limiting potential diversion.”

She called for better federal guidance “to support patient access.”

State opioid tax

D’Angelo said a state excise tax on most opioids, approved by the New York Legislature in 2019 as part of the state budget, aggravates the problem.

Wisconsin-based Independent Pharmacy Cooperative stopped selling opioids covered by the excise tax before it went into effect because “we thought that continuing to sell would likely mean that it would have been unprofitable,” said the company’s general counsel, Paul Karch. Last year, the company stopped selling all opioids nationwide because of high monitoring costs, he said.

Assemb. Linda Rosenthal (D-Manhattan), who headed the Assembly’s alcoholism and drug abuse committee when the tax was enacted, opposes the way the tax is structured because it can lead to higher prices for consumers, as well as lower supply. She called on the Department of Health to study the problem and find solutions.

Dr. Thomas Jan, a Massapequa pain management and addiction physician, said pain patients shouldn't have such difficulty obtaining prescribed medications. But, he said, in the past, many well-intentioned doctors were too quick to prescribe opioids, and they often prescribed too much, putting patients at increased risk of addiction. Jan said around 2010, his then-16-year-old son was prescribed 90 Vicodin pills after having a wisdom tooth pulled.

Dr. Yili Huang, a regional manager for pain management services for Northwell Health, said additional controls have caused doctors to think more carefully about alternatives to opioids. But opioids still have an important role, especially in relieving pain after surgery and for cancer, palliative and end-of-life care, he said.

Yet some doctors are hesitant to prescribe opioids, for fear of being “stigmatized as a doctor that prescribes a lot of opioids,” Huang said.

Rubin said he is conscious of the risk of developing dependence or addiction to opioids, so about nine in 10 of his new patients “probably will never see an opioid."

“We have more options than we ever had to treat patients with injections and those types of therapies,” he said.

Rubin most often writes opioid prescriptions for patients in severe pain after major surgery. For chronic pain patients who previously weren't prescribed opioids, “we’re really trying to save it as a last resort," he said.

The CDC’s 2022 guidance for opioid prescribing says there is insufficient evidence to determine the long-term benefits of opioid therapy for chronic pain. But, the CDC said, doctors should carefully weigh the risks and benefits of discontinuing opioids for those already prescribed them.

Rubin is reluctant to take chronic pain patients off opioids if the medication has been helping them long-term.

“There are lawyers and accountants and people like that who couldn't sit in a chair all day and work at their desk without their pain medicine,” he said. “Society has to separate those people who are using medication judiciously and not lump them in with people who are trying to take high doses in an abuse-type situation to get high.”

Latest videos

Critical LI Information You NeedDigital Access$1 for 5 months
ACT NOWSALE ENDS SOON | CANCEL ANYTIME

Title:

Content: Health · Life
New drugs, good drugs, more access to major diseases, more powerful protection
National Medical Insurance Bureau interpretation of the "14th Five-Year" medical insurance benefits will release what dividends
October 01, 2021 11: 11 Source: People 's Daily Online
BEIJING, Oct. 1 (Reporter Cui Yuanyuan) During the "14th Five-Year Plan" period, the direct settlement rate of hospital expenses across provinces will be increased from 50% to 70%, and more good drugs and drug administration will be included in the medical insurance catalogue in a timely manner.
A few days ago, the National Medical Insurance Bureau carried out an in-depth interpretation of the first five-year plan in the field of medical security - the "Fourteenth Five-Year Plan" (hereinafter referred to as the "Plan").
During the 14th Five-Year Plan period, China's elderly population over the age of 60 will exceed 300 million, society will enter a stage of moderate aging, the working-age population will decline, and the ratio of active retirement will further decrease.
At the same time, the urbanization rate of China's resident population has reached 60 percent, and the end of the 14th Five-Year Plan will reach 65 percent.
With the changes in disease spectrum, the risks of traditional infectious diseases and new infectious diseases such as COVID-19 are intertwined, the expenditure of the medical insurance fund has just been continuously expanded, and the pressure on the operation of the fund continues to exist.
In this regard, the National Medical Insurance Bureau said that the "Plan" is based on ensuring people's health, and promotes the high-quality development of medical insurance from the three dimensions of improving the multi-level medical security system system, optimizing the coordinated management system of medical security, and building a solid medical security service support system.
Through the efforts of the next five years, the masses can benefit from at least the following four aspects, namely, better access to new drugs and good medicines, stronger protection for major diseases, more balanced levels of inpatient and outpatient protection, and more convenient public services for medical insurance.
During the 14th Five-Year Plan period, it is more convenient for the masses to participate in insurance.
During the "14th Five-Year Plan" period, the participation rate remained above 95%, which is higher than the quality required by the "13th Five-Year Plan".
According to the National Medical Insurance Bureau, it is reflected in the following aspects:
The insurance policy is better.
Promote more workers and urban and rural residents to participate in insurance at their places of permanent residence and employment.
We will improve the ways in which flexible employees, including those employed in new forms of employment, can participate in the insurance scheme, and steadily implement the plan for the participation of all people, so as to consolidate and increase the coverage rate.
Second, the insurance service is better.
Through medical insurance and tax, commercial banks and other units to carry out "online and offline" cooperation, enrich the channels for payment of insurance premiums, and make it more convenient for the masses to apply for insurance.
Third, the management of insurance is more intelligent.
Through the national unified medical security information platform, the national insurance information interconnection and interconnection, repeated insurance participation, missed insurance, and termination of insurance will be further reduced.
Improve the insurance database covering the whole people, and realize real-time dynamic query of insurance information.
Establish and improve data sharing and exchange mechanisms with departments such as public security, civil affairs, human resources and social security, health and health, market supervision, taxation, education, rural revitalization, and disabled association, and strengthen departmental data comparison.
Fourth, the transfer of basic medical insurance relations is more smooth.
To meet the needs of population mobility and employment transformation, smooth the channels for the transfer and continuation of basic medical insurance relations across coordinated areas, and promote the transfer of basic medical insurance relations to continue cross-provincial operations.
The medical burden of insured people is further reduced
The provincial direct settlement rate for hospitalization expenses will be increased from 50% to 70%.
The National Medical Insurance Bureau explained that during the "14th Five-Year Plan" period, the proportion of fund payment within the policy scope of employee medical insurance and resident medical insurance hospitalization expenses was expressed as stable and richer, reflecting the improvement of the quality of protection.
First, this stability is in the context of gradually expanding the overall coordination of outpatient services, hospital and outpatient treatment is more balanced.
Second, this stability is the stability under the dynamic adjustment mechanism of the medical insurance catalog, the catalog is more flexible, and more good drugs and drugs are included in the catalog in a timely manner.
Third, this stability is more convenient and stable, and the direct settlement rate of hospitalization expenses will be increased from 50% to 70%.
Fourth, this stability is a more perfect stability for the protection mechanism of major diseases, which will help to promote the establishment of a long-term mechanism for preventing and resolving poverty caused by disease and returning to poverty.
The proportion of personal health expenditure will fall to 27%.
In the 13th Five-Year Plan period, the proportion of personal health expenditure in China's total health care expenses dropped from 29.27 percent to 27.7 percent. We will continue to reduce the proportion of personal health expenditure through measures such as improving the basic medical insurance system and increasing government investment, and continuously reduce the burden of medical expenses for the masses.
At the same time, considering that the external environment of economic development in the next five years is still more uncertain factors, the growth rate of financial investment in medical care is difficult to maintain the past growth rate, according to the principle of positive stability and leave room, the target is set at 27%.
The State Medical Insurance Bureau said that it will continue to do a good job in ensuring maternity insurance for women workers' maternity medical expenses and maternity allowances.
Second, standardize the management of the payment of reproductive medical expenses, promote the reform of the payment method of reproductive medical expenses, pay for hospitalized births according to the disease, and pay for prenatal examinations according to the head of the person, control the unreasonable increase of reproductive medical expenses, reduce reproductive costs, and improve the effectiveness of combining maternity insurance with basic medical insurance for employees.
Third, continue to do a good job of urban and rural residents basic medical insurance insured personnel maternity medical expenses treatment.
We need more good drugs, new drugs.
During the 14th Five-Year Plan period, the dynamic adjustment mechanism of pharmaceutical, medical consumables and medical services medical insurance catalogues will be established and improved.
According to the National Medical Insurance Bureau, in terms of medical insurance drug catalogues, one is unified.
Continue to promote the digestion of additional drugs at the provincial level, and ensure that the scope of basic medical insurance drugs is basically unified by 2022.
The second is normalization.
Establish and improve the medical insurance drug catalogue adjustment rules and indicator system, timely integrate drugs with high clinical value, obvious benefits for patients and excellent economic evaluation into the scope of drug payment according to the procedures, and support drug innovation.
Eligible Chinese medicine will be included in the scope of medical insurance payment according to the regulations.
Improve the evaluation mechanism of medical security drugs, strengthen the monitoring of the landing status of drug catalogues and the evaluation of innovative drugs.
Three is standardization.
Establish and improve medical insurance drug payment standards, with the negotiation of drugs, centralized procurement of drugs and "two diseases" drug payment standards as the entry, and gradually promote the convergence of drug catalogue management and payment standards.
In terms of medical consumables management, the medical consumables medical insurance access system is established, and the medical consumables catalog is formulated.
Explore the formulation of medical consumables medical insurance payment standards, guide and standardize medical service behavior, and promote the rational use of medical consumables.
In terms of medical service project management, improve the scope management of medical insurance service projects, clarify the medical insurance access, payment and supervision policies for medical service projects, and standardize medical service behavior.
On the basis of standardized details and unified connotations, a scientific, fair and transparent mechanism for access and dynamic adjustment of medical service projects will be gradually established to promote the orderly development of new technologies for medical services.
During the "14th Five-Year Plan" period, the reform of centralized procurement of drugs and medical consumables will be improved.
The National Medical Insurance Bureau introduced that it will increase the centralized procurement of drugs and medical consumables, promote the centralized procurement of medical consumables to become the dominant mode, normalize and institutionalize the centralized procurement of drugs, and continue to expand the centralized procurement of high-value medical consumables.
At the same time, the "Plan" put forward measures to support the development of traditional Chinese medicine in the tasks of catalogue management and payment management.
According to the State Medical Insurance Bureau, China will include eligible Chinese medicine in the scope of medical insurance payment according to regulations, support eligible Chinese medicine medical services to be included in the scope of medical insurance payment according to regulations, explore medical insurance payment methods that meet the characteristics of traditional Chinese medicine, encourage the practice of Chinese medicine with the same effect and price, and guide grass-roots medical institutions to provide appropriate Chinese medicine services.
In order to further benefit the people, the "14th Five-Year Plan" period will also expand the coverage of medical security designated medical institutions and medical security designated retail pharmacies, and more qualified grass-roots medical institutions will be included in the scope of medical insurance designated points.
Development of "smart medical insurance" services more convenient
During the "14th Five-Year Plan" period, promote the development of smart medical insurance and improve the quality of medical insurance convenient services.
According to the National Medical Insurance Bureau, the "Plan" puts forward the task of medical insurance information construction from the aspects of management, services and infrastructure.
These include, inter alia, the following:
One is to strengthen the construction of information infrastructure.
We will comprehensively build a unified national medical security information platform, continuously optimize the operation and maintenance system and safety management system, and improve the platform's functions.
Promote data migration, cleaning and other work to improve data quality.
Establish and improve the physical security, data security, network security and other security management systems and cloud platforms, business systems, networks and other operation and maintenance systems.
Deepen the application of technologies such as big data and blockchain in macro-decision analysis and medical electronic bills.
The second is to use smart health insurance to strengthen management.
Comprehensive establishment of intelligent monitoring system.
Actively explore new payment methods such as paying according to disease diagnosis related groups, paying according to the value of the disease, and new formats such as "Internet + medical health" and long-term care insurance will be included in the scope of intelligent monitoring.
Third, increase the level of service.
The use of information technology to improve the quality of medical insurance convenient services.
Encourage the development of inter-clinic settlement, bedside settlement and online settlement, promote the use of medical electronic bills, and support key regions to expand the scope of "inter-provincial and inter-provincial" administrative services.
Using information technology, improve the efficiency of direct settlement of medical treatment in different places.
Continue to optimize the online business process and provide more intelligent age-appropriate services.
Four is to promote data sharing.
Through the national integrated government service platform, cross-regional and cross-departmental data sharing can be achieved, medical insurance data can be classified and managed, and information sharing mechanisms with health, drug supervision and other departments are explored.
Explore and promote information sharing between medical security information platforms and commercial health insurance information platforms in accordance with regulations.
Business health insurance to meet the diverse needs of the population
Commercial health insurance plays an important role in meeting the diverse health needs of the masses.
The National Medical Insurance Bureau pointed out that to promote the development of commercial health insurance, we must work together in product innovation, policy innovation, mechanism innovation and regulatory innovation.
First, encourage innovation in commercial insurance products, provide comprehensive health insurance products and services in various fields, including medical treatment, disease, rehabilitation, care and fertility, and support insurance companies and traditional Chinese medicine institutions to cooperate in health management services.
More attention should be paid to giving full play to the role of commercial medical insurance, guiding insurance institutions to innovate and improve the content of insurance, and improving the level of insurance and service capabilities.
The second is to strengthen cooperation between basic medical insurance and commercial insurance.
Encourage commercial insurance institutions and other social forces to participate in medical insurance management services, and introduce social forces to participate in long-term care insurance management services.
Commercial insurance companies are encouraged to develop commercial long-term care insurance products.
Third, improve the support policy.
Support commercial insurance institutions to develop commercial health insurance products linked to basic medical insurance, better cover the costs not paid by basic medical insurance, and meet the diversified protection needs of the people.
Explore and promote information sharing between the national medical security information platform and the commercial health insurance information platform in accordance with regulations.
The fourth is to implement the responsibilities of industry regulatory departments, strengthen market behavior supervision, and highlight the supervision of key links such as health insurance product design, sales and compensation.
(Editor: Cui Yuanyuan, Lu Qian)
Related News

S.

dollars.

Title:

Content: Friday 17 November 1443 AH - 17 June 2022 |
Programs
Watch our latest episodes online
Araji: Consumption of medicine more than 2020 by about 800 million dollars means that there is smuggling and must be controlled
The Health Committee held a session chaired by MP Assem Araji and attended by MPs: Enaya Ezzedine, Pierre Bou Assi, Amin Shri, Ali Mekdad, Bilal Abdullah, Mohammed Al-Qarawi, Salim Khoury, Fadi Saad and Fadi Allama.
The meeting was attended by Dr. Mahmoud Zalzleh, Executive Director of Parts and Operations at Banque du Liban (Banque du Liban), President of the Pharmaceutical Importers Association Karim Jabara, Marwan Hakeem, President of the Medical Importers Association Salma Assi, President of the Pharmacists Association Ghassan Al-Amin, and the pharmaceutical factories Carole Abi Karam and Berta Abi Zeid.
The committee discussed the reasons for the loss of some drugs from the market.
After the session, the chairman of the committee, MP Araji, said: “Today, for three and a half hours, we discussed the medicine crisis experienced by all Lebanese.
There are drugs related to heart disease, diabetes, epilepsy and incurable diseases, that is, for all kinds of diseases.
There are medicines that are cut off and people are searching for the medicine from one area to another, even if it is sold at double the price, but these are very few and exploit people, while 90 percent of the pharmaceutical sector suffers.
The problem is that there are medicines in hospitals, so if someone suffers from low pressure or blood poisoning, if they are not given these medicines, they may die.
So, there is a difficulty in the hospital care departments because there are medicines that are only used in the care rooms and they are missing. ”
He added: "The pharmacist holds the warehouse responsible because he does not deliver medicine, and I confirm that the pharmacist is oppressed because he is in the barrel of the gun, and the warehouse holds the importer responsible and the last holds it to the Bank of Lebanon, which in turn carries it to the importer.
Over the course of 3 and a half hours, each party has different figures than the second, and the problem is that the government, when it developed the support plan so far, we put the so-called rationalization of drug support, and so far the government is not able to take a decision and it is throwing the issue on the House of Representatives.
The government has to make a decision quickly because the story is lost, and the reason is smuggling medicine out of Lebanon, unfortunately, at a time when the Lebanese need medicine, which is a crime.
Therefore, the subject of penalties with regard to medicine and all goods is supposed to increase the penalty, not to enter the person for 15 days and then leave.
We note that there are those who buy cancer drugs with thousands of dollars and put them in their pockets and leave for the nearest country of Cyprus, Turkey and others, sell them and earn thousands of dollars, and if found out he will be imprisoned for 15 days! ”
He continued: "The situation of medicine is very difficult, so what is required of the security services of customs and security forces and the ministerial committee, especially the government, which is supposed to act, even if it is a resigned government, but it is not permissible to resign from the health security of the people, and this is a serious issue.
We noticed that some pharmacies in Bekaa, Metn or Dahiya were closed because they no longer had medicines.
This led me and the minister of health to meet with the governor of the Central Bank of Lebanon last Thursday.
We discussed the matter with him in the presence of the adviser of the Minister Dr. Mahmoud Zalzla and responsible for the support related to medicine, Mr. Noman Ndour, and we said that the situation is no longer bearable.
The governor gave us figures that were very different from those provided by drug importers.
The governor says that in 2020 he gave them $173 billion, which is acceptable, and he issued a statement saying that we gave them $485 million until May 20, that is, since the beginning of the year, and there are bills submitted by $535 million, and another from May 10 to 20 of it worth $212 million.
He says if I continue like this I will pay the equivalent of two and a half years to support the medicine.
We agreed to form an audit committee from the Banque du Liban and the Ministry of Health, which began work the next day, Friday.
They also met on Saturday and today to find out which bills are coming into the country in exchange for a subscription or not.
They gave us pencils and said it was true that the import of medicine in 2021 was more than in 2020 because of Coronavirus, smuggling and storage, and that there was almost $100 million more than the first four months.
This is what importers say, in just a year, about $800 million more than last year.
Suppose this figure is correct, ask: if you have taken, as in the past year, and it is known that Lebanon consumes $100 million between medicine and medical supplies every month, that is, the Banque du Liban paid them 400 million during the first months and says 85 increase Coronavirus, smuggling and storage, or 485 million dollars.
So, where's the medicine, of course there's smuggling to make empty profits and we have the cheapest medicine in the area.
All of them want to escape and here is the responsibility of the security services and customs and they are supposed to control smuggling. ”
“Some drug importers have admitted to having a portion in their warehouses, and the question is why they don ’ t deliver or distribute the medicines, ” he said.
They say the Banque du Liban (BDL) has asked for pre-approval, meaning that even after the medicine is brought into Lebanon, the BDL wants pre-approval for delivery.
But we are in a crisis, and we wished for them to distribute the medicine, and for the Banque du Liban, and this is what we told his representative at the meeting today, to convey to the governor that 485 million dollars and 535 million and 212 thousand were spent according to priorities in order to provide medicine in the country, and some of them are in stores because there are problems between the Banque du Liban and pharmaceutical companies.
"We also talked about the interruption of medical supplies.
And as you know who will enter the hospital if he has a car or a piece of land, he will sell them because everything the patient needs is in dollars, and the captain of the importers of medical supplies says I am a Muslim, but I am not responsible if, as I said, each side throws the charge on the other, and the hospitals take “Fresh Money ” (cash) and I do not enter and hand them 85.15 Some colleagues also have information that medical supplies are sold in hospitals, and the hospital syndicate says no, so we live in a bird. ”
“For hours of discussions we couldn ’ t figure out who was responsible.
And I know the truth about those, my friends and colleagues, but we did not understand from them the truth about whom and each side throws the blame on the other.
I believe that the state bears part and the resigned government is supposed to do its duty and we made a great effort with His Excellency the Minister to alleviate the suffering, but nothing can be done if the government does not take its role and take decisions to protect the national pharmaceutical industry.
We hoped that the ruler would act quickly for the sake of the national industry to save it from this critical situation and not to export medicines abroad, and at the same time, we should increase the prescription of generic, incurable and cancerous medicines.
I hope that colleagues will not give prescriptions because we have heard that there are prescriptions given under fictitious names in order to avoid this subject, and the Medical Syndicate should intervene and take the necessary measures. ”

**Drug Smuggling**: A significant portion of

Title:

Content: POLITICAL
Health Minister: Some subsidized medicines are smuggled to neighboring countries
Acting Minister of Health Dr. Haitham Mohamed Ibrahim stressed that the issue of providing medicine is a national security issue.
The minister confirmed during his speech to (the scene program) the continuation of support for seven hundred and two types of medicines for medical supplies and said: "But unfortunately there is smuggling of some types of medicines supplies to neighboring countries, including what is seized and others are not seized."
He announced the approval of a map to promote national pharmaceutical manufacturing.
Ibrahim acknowledged that the medicine was seriously affected by the economic situation and noted that 80 percent of the medicines were imported from abroad.
The Minister in charge called for the need to finance health insurance as the funds allocated to him are without ambition, expressing his dissatisfaction with the level of emergency services in government hospitals and said: "A national strategy has been developed to develop emergency," revealing a proposal to develop a fee from traffic services to treat emergency cases and implement the strategy that provided dozens of first aid.
Khartoum: Abu Bakr Mahmoud
The Next Day Newspaper

Title:

Content: Medicines crisis to release...
Minister of Health: If necessary, we will issue a price index more than once a week
Salwa Baalbaki – The Day
The storm of collapse with its economic depression continues, and its latest tragic “achievement ” is the loss of most types of medicines and supplements, as well as medicines and infant formula.
In the past two years, the Lebanese used to lose medicines that were covered by the ill-fated subsidies, but after the lifting of subsidies, the pharmaceutical market stabilized relatively with some imbalances in cancer drugs that remained subsidized. However, the resumption of the dollar ’ s upward movement brought the crisis back to square one. The protection of their investments in a preventive step is mainly caused by the rapid rise of the exchange rate, as it exceeded 6 thousand pounds in four days, which is not possible for importers and pharmacists to withstand and continue.
The heads of pharmacists, drug importers and warehouse owners in Lebanon, Joe Salloum and Karim Jabara, raised their voices yesterday, warning of the inevitable bankruptcy of pharmaceutical companies and institutions and their complete cessation of work.
The two captains acknowledged the dilemma of the interruption of medicines resulting from fluctuations in the exchange rate of the national currency, and insisted on the need for the Ministry of Health to issue a weekly price index, in accordance with the relevant ministerial decisions.
Failure to take up this crucial issue to ensure the continuity of the supply of medicine to the market will inevitably lead to the failure of pharmaceutical institutions in general and their inability to follow up on the needs of Lebanese patients.
They said in a joint statement that the issue of updating the drug price tables, “is not only related to the financial process or the indicators of profit and loss, but it threatens the viability of pharmaceutical institutions.
If these institutions continue to sell medicine at a low exchange rate, as is the case today, they will no longer be able to replenish their stocks, and repeating this process will lead to serious consequences, including the inevitable bankruptcy of pharmaceutical institutions and their complete cessation of work. ”
On the other hand, the Minister of Public Health Firas Al-Abyad does not blame either party, and says to “Al-Nahar ”:“ It is not out of defense of them, but in fact they have capital they want to work with, and if they lose even a bit of it weekly, they will inevitably declare bankruptcy after a few months. ”
He stressed that he is responsive to their demands, and “I understand their position on changing the price of the index with the continuous rise of the exchange rate, so I am ready to issue an index twice a week if the need arises, and if this addresses the problem, but in return they have to take out the goods they hide to provide medicines to citizens sustainably. ”
"The problem is not limited to infant formula and medicines, but includes all medicines that are not subsidized.
Subsidies protect medicines from exchange rate fluctuations, and the state here is concerned with the issue and eats hands whenever the exchange rate rises. ”
“When the exchange rate changes, the change in the prices of subsidized medicines cannot be seen as a small change, but the change is evident in the prices of unsubsidized medicines, ” he said.
So the pharmacist, like the trader, is slow to sell the unsubsidized drug while waiting for the new index to be issued, perhaps he will notice the rise in the exchange rate. ”
While the steady and rapid rise in the price of the dollar on the black market has resulted in almost complete cessation of the delivery of medicines and milk to pharmacies, and thus gradually losing them, but there is no doubt that the storage and smuggling operations continue, especially infant formula, which is still supported by 50%. They sell medicines and milk from Lebanon at market prices, and they sell them in Iraq, which is suffering from several crises.
In addition, the Lebanese have been buying medicine for more than a week as a result of the crazy rise in the dollar exchange rate.
The biggest rush is to buy medicines for chronic diseases because of the fear of interruption, and there is a great rush to buy subsidized milk, especially for infants, which is already delivered by companies to pharmacists only in small quantities.
Three new factories...
The old one is expanding.
The renewed drug crisis has reiterated the need to strengthen and support the production of medicines locally and rely on the expertise of the industrial sector, which if it has a set of tax and customs elements and international agreements can, according to more than one study, secure more than 70% of the need of the market and export and quality and international specifications.
Three pharmaceutical factories under construction have applied this year through the Public Corporation for Investment Promotion in Lebanon (IDAL), with investments estimated at $200 million, creating about 600 jobs, IDAL consultant Abbas Ramadan told An-Nahar.
Among them is a factory in Zahle for the manufacture of advanced cancer drugs, the largest project with an estimated investment of more than $130 million.
The other two factories, one in the north (about $15 million) and the other in the south ($35 million), manufacture various types of medicines, including needles that need more advanced technology than others.
These factories need at least three years to start operations, according to the former president of the Association of Industrialists and one of the largest pharmaceutical manufacturers in Lebanon, Jacques Sarraf, especially that any new production process, in addition to the requirements of the construction of the plant and the introduction of equipment from time to time, must be accompanied by the registration of medicines locally and abroad, in parallel with the provision of health conditions required GMP
Good Manufacturing Practice for Building Laboratories.
This is in addition to the time required to conduct experiments on the equipment required for work and ventilation equipment.
Investment in the pharmaceutical sector, Sarraf says, requires time and precision before production begins.
Export requires additional measures, especially that external institutions will not deal with any new factory if they do not see that the factory is operating in accordance with international standards.
Based on the fact that any factory does not expand means that it is declining, and that investment in the pharmaceutical industry is a permanent investment, Sarraf confirms that the current pharmaceutical factories, which include 12 factories, are constantly expanding, producing about 35 new medicines annually and covering about 48% of the local market needs, including two factories that produce serum and cover the entire local consumption.
The 12 factories employ between 5,000 and 7,000 employees.

Title:

Content: Expressionist Reuters
Buying drugs through social media in Egypt.. what next?
(Video toss)
The phenomenon of the indiscriminate sale of medicines through social media is a health disaster that threatens the health of millions of Egyptians because it is not subject to supervision or inspections by the Ministry of Health.
These drugs, which reach Egyptians ’ homes through the delivery service Delivery.com, are of unknown origin in terms of manufacturing and storage, and the brand may be counterfeit, putting health and the economy at great risk.
Stakeholders have estimated the volume of electronic drug trade globally for 2021 at nearly $300 billion, while the concerned authorities call for deterring this trade by taking new measures, which emphasize control and punishment and a new legislation to practice the profession of pharmacy.
Most Read
No stories found.
Erm News
www.eremnews.com